Page last updated: 2024-08-17

levodopa and Cognition Disorders

levodopa has been researched along with Cognition Disorders in 184 studies

Research

Studies (184)

Timeframe	Studies, this research(%)	All Research%
pre-1990	20 (10.87)	18.7374
1990's	25 (13.59)	18.2507
2000's	74 (40.22)	29.6817
2010's	64 (34.78)	24.3611
2020's	1 (0.54)	2.80

Authors

Authors	Studies
Dowiasch, S; Sommerkorn, J; Stock, L; Student, J; Timmermann, L; Waldthaler, J	1
Bichon, A; Boyer, F; Broussolle, E; Castrioto, A; Chabardès, S; Fraix, V; Kistner, A; Klinger, H; Krack, P; Lhommée, E; Mertens, P; Pélissier, P; Schmitt, E; Thobois, S; Wack, M	1
Fragola, M; Giannini, G; Lakens, D; Mirabella, G; Modugno, N	1
Pandey, S; Singh, B; Yadav, SK	1
Andréasson, M; Brodin, L; Laffita-Mesa, JM; Svenningsson, P	1
Hagell, P; Iwarsson, S; Nilsson, MH; Odin, P; Rosqvist, K; Storch, A	1
Brooks, D; Poewe, W; Ray Chaudhuri, K	1
Cova, I; Priori, A	1
Bezard, E; Charvin, D; Conquet, F; Di Paolo, T; Duvey, G; Gregoire, L; Halldin, C; Medori, R; Pioli, E; Takano, A	1
Amorim, BJ; Barsottini, OGP; Faber, I; França, MC; Friedman, JH; Lopes-Cendes, Í; Lourenço, CM; Maia, ML; Marques, W; Martinez, ARM; Martins, CR; Montecchiani, C; Orlacchio, A; Pedroso, JL; Ramos, CD; Souza, JP	1
Abe, O; Aoki, S; Hattori, N; Hori, M; Ito, K; Kamagata, K; Kuwatsuru, R; Motoi, Y; Nakanishi, A; Sano, T; Sasai, K; Shimoji, K; Suzuki, M; Tomiyama, H	1
Ardouin, C; Benabid, AL; Chabardès, S; Debû, B; Ferraye, MU; Fraix, V; Krack, P; Lhommée, E; Pollak, P; Seigneuret, E	1
Chen, Y; Deng, L; Li, J; Qin, X; Sun, H; Tang, R; Yi, L; Zhang, C; Zhang, L; Zhang, Z; Zheng, J; Zhou, H	1
Damier, P; Derkinderen, P	1
Daniels, C; Deuschl, G; Falk, D; Granert, O; van Eimeren, T; Volkmann, J; Witt, K	1
Amboni, M; Annesi, G; Barbosa, ER; Barone, P; Bonifati, V; Breedveld, GJ; Chien, HF; Erro, R; Fang, M; Graafland, J; Olgiati, S; Oostra, BA; Pappatà, S; Picillo, M; Quadri, M; Quarantelli, M; Quattrone, A; Wang, J; Wu, B; Xu, F	1
Destee, A; Gao, H; Graf, A; Hattori, N; Hauser, RA; Kenney, C; Lang, AE; Merschhemke, M; Nagel, J; Poewe, W; Rascol, O; Stacy, M; Stocchi, F; Tolosa, E; Trenkwalder, C	1
Aricò, D; Cosentino, FI; Ferri, R; Pizza, F; Plazzi, G	1
Bohnen, NI; Kwak, Y; Schonfeld, D; Seidler, R; Vaillancourt, DE	1
Caramelli, P; Cardoso, F; Vale, TC	1
Corona-Morales, AA; Hernández, VS; Jáuregui-Huerta, F; Luquín, S; Medina, MP; Ruíz-Velasco, S; Zhang, L	1
Takeda, A	1
Gelfius, CD; Mortimer, D; Potts, MA	1
Cáceres-Redondo, MT; Carballo, M; Carrillo, F; Huertas-Fernández, I; Lama, MJ; Mir, P; Vargas-González, L	1
Nagy, H; Radics, P; Takáts, A; Tamás, G; Tóth, A	1
Eidelberg, D; Ko, JH; Lerner, RP	1
Burn, DJ; Galna, B; Lord, S; Rochester, L	1
Hanna-Pladdy, B; Lyons, KE; Pahwa, R	1
Cruz, AV; Delaville, C; Gerber, CM; McCoy, AJ; Walters, JR	1
Dorban, S; Gustin, T; Mormont, E	1
Ben El Haj, R; Benomar, A; Bouhouche, A; Bouslam, N; Regragui, W; Skalli, A; Tazi-Ahnini, R; Yahyaoui, M	1
Bezard, E; Camus, SM; Ko, WKD; Li, Q; McGuire, S; Pioli, EY; Yang, J	1
Bonenfant, J; Drapier, S; Haegelen, C; Houvenaghel, JF; Naudet, F; Sauleau, P; Vérin, M	1
Feng, H; Peng, S; Xiao, J; Xie, Y; Zhang, J	1
Fox, SH; Lang, AE	1
Auerbach, S; Cronin-Golomb, A; Durso, R; Harris, E; McNamara, P; Stavitsky, K	1
Jeon, BS; Kim, DG; Kim, HJ; Kim, JY; Lee, JY; Lim, YH; Paek, SH	1
Gluck, MA; Guthrie, M; Myers, CE	1
Comella, C; Elmer, L; Hauser, RA; Lyons, KE; Pahwa, R; Simuni, T; Weintraub, D	1
Allert, N; Eleopra, R; Houeto, JL; Moro, E; Phan, TM; Stoevelaar, H	1
Członkowska, A; Leśniak, M; Litwin, M; Litwin, T; Seniów, J	1
Diederich, NJ; Fénelon, G; Goetz, CG; Stebbins, G	1
Stacy, M	2
Allard, M; Burbaud, P; Cuny, E; Farid, K; Guehl, D; Sibon, I	1
Cho, JY; Cho, YJ; Hong, KS; Jeon, BS; Kim, HJ; Lee, DH; Park, SY; Seo, SY	1
Aguilar, E; Barbanoj, M; Kulisevsky, J; Marin, C; Pérez, V; Rubio, A	1
Baldacci, F; Berti, C; Bonuccelli, U; Lucetti, C; Nuti, A; Poletti, M	1
Racette, BA; Sterling, C; Willis, AW	1
Calopa, M; Campdelacreu, J; Jaumà, S; Juncadella, M; Miró, J; Sánchez-Castañeda, C	1
Alty, JE; Clissold, BG; Kempster, PA; McColl, CD; Reardon, KA; Shiff, M	1
Litvinenko, IV; Mogil'naya, VI; Odinak, MM; Perstnev, SV	1
Gabriel, D; Guggisberg, A; Morand, S; Nahum, L; Schnider, A	1
Byrne, GJ; Dissanayaka, NN; Marsh, R; Matheson, S; Mellick, GD; O'Sullivan, JD; Sellbach, A; Silburn, PA	1
Iliceto, G; Lamberti, P; Lamberti, SV; Logroscino, G; Santamato, A; Zoccolella, S	1
Espay, AJ; Metman, LV; O'Sullivan, JD; Paviour, DC; Revilla, FJ; Schmidt, RE	1
Bugalho, P; da Silva, JA; Neto, B	1
Brotchie, JM; Fox, SH	1
Kishore, A; Krishnan, S; Panikar, D; Rao, R; Sarma, G; Sarma, S; Sivasanakaran, MP	1
Danysz, W; Dekundy, A; Gravius, A; Hechenberger, M; Mela, F; Nagel, J; Parsons, CG; Pietraszek, M; Tober, C; van der Elst, M	1
Auclair-Ouellet, N; Cantin, L; Chantal, S; Langlois, M; Macoir, J; Prud'homme, M	1
Lang, AE; Potenza, MN; Siderowf, AD; Sohr, M; Stacy, M; Voon, V; Weintraub, D; Whetteckey, J; Wunderlich, GR	1
Azlin, B; Fazli, A; Rosdinom, R; Ruzyanei, NJ; Srijit, D	1
Belcastro, V; Calabresi, P; Castrioto, A; Gallina, A; Rossi, A; Tambasco, N	1
Delbari, A; Lokk, J; Salman-Roghani, R	1
Artigas, CF; Espino Ibáñez, A; Masmiquel Comas, L; Nicolau Ramis, J; Rivera Irigoín, R	1
Jahanshahi, M; Obeso, I; Wilkinson, L	1
Dhawan, V; Eidelberg, D; Ma, Y; Mattis, PJ; Tang, CC	1
DeLong, MR; Factor, SA; Smith, Y; Wichmann, T	1
Krajcovicova, L; Marecek, R; Mikl, M; Rektorova, I	1
De Deurwaerdère, P; Navailles, S	1
Cercy, SP; Marasia, JC	1
Eidelberg, D; Feigin, A; Niethammer, M	1
Canning, CG; Fung, VS; Paul, SS; Sherrington, C	1
Artusi, CA; De Angelis, C; Lopiano, L; Marchisio, A; Merola, A; Montanaro, E; Reggio, D; Ricchi, V; Rizzi, L; Rizzone, M; Zibetti, M	1
Ankaralı, H; Gunal, DI; Mollahasanoğlu, A; Ozen Barut, B; Turkmen, C	1
Wurtman, RJ	1
Agosti, V; Amboni, M; Barone, P; Fasano, A; Iavarone, A; Iuppariello, L; Lista, I; Picillo, M; Santangelo, G; Sorrentino, G; Tranfaglia, R; Vitale, C	1
Bezard, E; Jianzhong, Y; Li, Q; Pioli, EY; Schneider, JS	1
Pagonabarraga, J; Rodríguez-Oroz, MC	1
Dunnett, SB; Lane, EL; Lelos, MJ	1
Nieoullon, A	1
Huang, Z; Jacewicz, M; Pfeiffer, RF	1
Manoach, DS; Mechanic, DJ; Press, DZ; Tarsy, D	1
Czernecki, V; Dubois, B; Houeto, JL; Levy, R; Pillon, B; Pochon, JB	1
Sulkava, R	1
Bassi, A; Boffa, L; Brusa, L; Caramia, MD; Peppe, A; Pierantozzi, M; Ruggieri, S; Stanzione, P; Stefani, A	1
Ardouin, C; Benabid, AL; Fraix, V; Funkiewiez, A; Krack, P; Moro, E; Pollak, P; Van Blercom, N; Xie, J	1
Ho, SL; Lee, TM; Li, LS; Tsang, KL; Yip, JT	1
Antonini, A; Basile, G; Di Blasi, L; Di Raimondo, G; Di Rosa, AE; Epifanio, A; Imbesi, D; La Spina, P; Martino, G; Morgante, L; Stocchi, F; Tetto, A	1
Ginestroni, A; Marini, P; Paganini, M; Ramat, S	1
Ishizu, H; Kuroda, S; Terada, S	1
Agid, Y; Bonnet, AM; Cornu, P; Duyckaerts, C; Hauw, JJ; Houeto, JL; Jarraya, B	1
Appel, S; Evans, AH; Katzenschlager, R; Lawrence, AD; Lees, AJ; O'Sullivan, JD; Paviour, D	1
Drozdowski, W; Halicka, D; Kułakowska, A; Pogorzelski, R; Pyd, E	1
Marinus, J; Schipper, RGB; Stiggelbout, AM; van Hilten, JJ; Visser, M	1
Chen, CM; Lee-Chen, GJ; Tang, LM; Wang, CK; Wang, SC; Wu, YR	1
Kang, SY; Lee, MH; Lee, SK; Sohn, YH	1
Alonso-Prieto, E; Michel-Esteban, E; Palmero-Soler, E; Trujillo-Matienzo, C	1
Bares, M; Dostál, V; Ehler, E; Fanfrdlová, Z; Fiedler, J; Klajblová, H; Kulist'ák, P; Rektor, I; Rektorová, I; Ressner, P; Svátová, J; Urbánek, K; Velísková, J	1
Iakhno, NN; Zakharov, VV	1
Grosset, DG; Grosset, KA	1
Bowron, A; Guttman, M; Hauser, R; Hughes, K; Larsen, JP; LeWitt, P; Oertel, W; Quinn, N; Sethi, K; Stacy, M; Stocchi, F	1
Brugger, P; Fathi, M; Krummenacher, P; Landis, T; Mohr, C; Sandor, PS	1
De Reuck, J; De Weweire, M; Santens, P; Van Maele, G	1
Araujo Silva, MT; Barbosa, ER; Bermpohl, F; Boggio, PS; Fregni, F; Mansur, CG; Marcolin, MA; Odebrecht Rosa, M; Pascual-Leone, A; Rigonatti, SP; Rosa, M; Rumi, DO	1
Elovic, EP; Napolitano, E; Qureshi, AI	1
Farrugia, R; Felice, A; Neville, BG; Parascandalo, R	1
Armenise, E; de Mari, M; Defazio, G; Diroma, C; Fraddosio, A; Iliceto, G; Lamberti, P; Lamberti, SV; Livrea, P; Zoccolella, S	1
Bottiglieri, T; Diaz-Arrastia, R; Greenberg, SM; Growdon, JH; Gurol, ME; Hyman, BT; Irizarry, MC; Locascio, JJ; Raju, S; Tennis, M	1
Agid, Y; Bonnet, AM; Chastan, N; Cornu, P; Czernecki, V; Dormont, D; Hartmann, A; Houeto, JL; Mallet, A; Mallet, L; Maltête, D; Mesnage, V; Navarro, S; Pidoux, B; Schüpbach, WM; Welter, ML	1
Antonini, A; Bonetti, A; Cilia, R; De Gaspari, D; Landi, A; Mariani, CB; Morgante, L; Natuzzi, F; Pezzoli, G; Sganzerla, E; Siri, C	1
Merchant, TE	1
Durso, R; McNamara, P	1
Diamond, A; Jankovic, J	1
Hattori, T; Sakakibara, R; Uchiyama, T	1
Fuchs, G; Hahne, M; Klein, W; Müller, T; Schwarz, M	1
Burn, DJ; McKeith, IG; Molloy, SA; O'Brien, JT; Rowan, EN; Wesnes, K	1
Borek, LL; Friedman, JH; Kohn, R	1
Ransmayr, G	1
Kozhevnikova, ZhV; Krivonos, OV; Puzin, MN	1
Berendse, HW; Bosboom, JL; Deijen, JB; Stam, CJ; Stoffers, D; Wolters, EC	1
Hagell, P; Nygren, C	1
Holton, J; Kempster, PA; Lees, AJ; Revesz, T; Selikhova, M; Williams, DR	1
Biglan, KM; Holloway, RG; McDermott, MP; Richard, IH	1
Arabia, G; Cerasa, A; Fera, F; Gallo, O; Gioia, MC; Nicoletti, G; Pugliese, P; Quattrone, A; Romeo, N; Zappia, M	1
Levy, G	1
Baláz, M; Pulkrábek, J; Rektor, I	1
Barker, RA; Hampshire, A; Owen, AM; Williams-Gray, CH	1
Kawamura, M; Sato, T; Takahashi, N	1
Annesi, F; Annesi, G; Cirò Candiano, IC; Civitelli, D; D'Amelio, M; Quattrone, A; Ragonese, P; Salemi, G; Savettieri, G; Tarantino, P; Terruso, V	1
García-Sánchez, C; Gironell, A; Kulisevsky, J; Llebaria, G; Pagonabarraga, J; Pascual-Sedano, B	1
Friedrich, FJ; Posner, MI; Rafal, RD; Walker, JA	1
Portin, R; Raininko, R; Rinne, UK	1
Agid, Y; de Smet, Y; Dubois, B; Lhermitte, F; Ruberg, M; Serdaru, M	1
Boonen, S; Celen, H; Dom, R; Pelemans, W	1
Marsden, CD	2
Caparros-Lefebvre, D; Duhamel, A; Pécheux, N; Petit, H; Petit, V	1
Bowes, SG; Charlett, A; Dickins, J; Dobbs, RJ; Dobbs, SM; Frith, C; Henley, M	1
Brownlee, HJ; Stacy, M	1
Gsell, W; Lange, KW; Naumann, M; Paul, GM	1
Hurtig, HI	1
Heberlein, I; Müller, U; Nitschke, M; Otto, V; Steinberger, D; Vieregge, P	1
Huh, K; Kim, GW; Kim, JS; Sohn, YH	1
Beric, A; Devinsky, O; Dogali, M; Eidelberg, D; Fazzini, E; Kolodny, E; Perrine, K; Sterio, D	1
Ben-Shlomo, Y; Brown, R; Marsden, CD; Quinn, N; Schrag, A	1
de Bruin, W; Hageman, G; Herholz, K; Steur, EJ; van der Hoek, J; van der Laan, G; van Hout, M	1
Lloyd, GK; Menzaghi, F; Schneider, JS; Tinker, JP; Van Velson, M	1
Agid, Y; Bédard, MA; Dubois, B; Duchesne, N; Masson, H; Pillon, B	1
Alegret, M; Junqué, C; Nobbe, FA; Rumià, J; Tolosa, E; Valldeoriola, F; Vendrell, P	1
Kumar, R; Lang, AE; Lozano, AM; Saint-Cyr, JA; Trépanier, LL	1
Kulisevsky, J	1
Barbanoj, M; Berthier, ML; Estévez-González, A; García-Sánchez, C; Gironell, A; Kulisevsky, J; Pascual-Sedano, B	1
Cyong, J; Itokazu, N; Ouchi, Y; Yamamoto, K	1
Ballard, C; Campbell, S; Stephens, S	1
Barker, RA; Cools, R; Owen, AM; Robbins, TW; Stefanova, E	1
Suchowersky, O	1
Ishimitsu, H; Nakasone, S; Namba, S	1
Anokhina, IP; Kudriavtsev, IA; Lukacher, GIa; Morozov, GV; Morozova, TG	1
Kristensen, V; Olsen, M; Theilgaard, A	1
Elithorn, A; Lunzer, M; Weinman, J	1
Guillard, A	1
Cooper, JA; Doherty, SM; Jordan, N; Sagar, HJ; Sullivan, EV; Tidswell, P	1
Bolzani, R; Cipolli, C; Massetani, R; Muratorio, A; Murri, L	1
James, M; Lange, KW; Marsden, CD; Owen, AM; Paul, GM; Robbins, TW	1
Cramer, H; Kuntzmann, F; Masson, H; Popescu, I; Strubel, D	1
Ahlskog, JE; Fealey, RD; Low, PA; Sandroni, P	1
Findley, L; Prasher, D	1
Bondarenko, NA; Kudrin, VS; Miroshnichenko, II; Rayevsky, KS	1
Agid, Y; Dubois, B; Lhermitte, F; Pilon, B	1
Bolduc, PL; Preziosi, TJ; Robinson, RG; Starkstein, SE	1
Agid, Y	1
Agid, Y; Bonnet, AM; Cusimano, G; Dubois, B; Lhermitte, F; Pillon, B	1
Dubois, B	1
Gil, R; Lefèvre, JP; Neau, JP; Rivasseau-Jonveaux, T; Toullat, G	1
Golden, WE; Lavender, RC; Metzer, WS	1
Berthier, ML; Bolduc, PL; Mayberg, HS; Preziosi, TJ; Robinson, RG; Starkstein, SE	1
Mair, RG; McEntee, WJ	1
Bowman, RE; Levin, ED; Vuchetich, J; Wegert, S	1
Imai, H; Komiya, T; Narabayashi, H; Usui, S	1
Duvoisin, RC; Sage, JI	1
Lang, AE	1
Portin, R; Rinne, UK	1

Reviews

36 review(s) available for levodopa and Cognition Disorders

Article	Year
Antisaccades in Parkinson's Disease: A Meta-Analysis. Neuropsychology review, 2021, Volume: 31, Issue:4 Topics: Cognition Disorders; Deep Brain Stimulation; Humans; Levodopa; Parkinson Disease; Subthalamic Nucleus	2021
Motor and Nonmotor Complications of Levodopa: Phenomenology, Risk Factors, and Imaging Features. Movement disorders : official journal of the Movement Disorder Society, 2018, Volume: 33, Issue:6 Topics: Antiparkinson Agents; Behavioral Symptoms; Cognition Disorders; Humans; Levodopa; Parkinson Disease; Risk Factors	2018
Diagnostic biomarkers for Parkinson's disease at a glance: where are we? Journal of neural transmission (Vienna, Austria : 1996), 2018, Volume: 125, Issue:10 Topics: alpha-Synuclein; Biomarkers; Brain; Cognition Disorders; Constipation; Depression; Early Diagnosis; Genetic Predisposition to Disease; Humans; Inflammation; Levodopa; Metabolomics; Microbiota; Movement Disorders; Neuroimaging; Olfaction Disorders; Parkinson Disease; REM Sleep Behavior Disorder; Symptom Assessment; Vision Disorders	2018
[Specificities of the treatment of Parkinson's disease in the elderly]. Psychologie & neuropsychiatrie du vieillissement, 2006, Volume: 4 Spec No 1 Topics: Aged; Antiparkinson Agents; Cognition Disorders; Dopamine; Dyskinesia, Drug-Induced; Humans; Levodopa; Parkinson Disease	2006
Dopamine overdose hypothesis: evidence and clinical implications. Movement disorders : official journal of the Movement Disorder Society, 2013, Volume: 28, Issue:14 Topics: Brain; Cognition Disorders; Dopamine; Dopamine Agents; Humans; Learning Disabilities; Levodopa; Parkinson Disease	2013
[Treatment possibilities in advanced Parkinson's disease]. Ideggyogyaszati szemle, 2013, Nov-30, Volume: 66, Issue:11-12 Topics: Administration, Oral; Age Factors; Antiparkinson Agents; Apomorphine; Carbidopa; Cognition Disorders; Deep Brain Stimulation; Dopamine Agents; Drug Tolerance; Duodenum; Dyskinesia, Drug-Induced; Gels; Humans; Infusion Pumps, Implantable; Levodopa; Parkinson Disease; Quality of Life; Severity of Illness Index	2013
Effects of levodopa on regional cerebral metabolism and blood flow. Movement disorders : official journal of the Movement Disorder Society, 2015, Volume: 30, Issue:1 Topics: Animals; Antiparkinson Agents; Cerebral Cortex; Cognition Disorders; Humans; Levodopa; Neuroimaging; Parkinson Disease; Regional Blood Flow	2015
Association of plasma homocysteine, vitamin B12 and folate levels with cognitive function in Parkinson's disease: A meta-analysis. Neuroscience letters, 2017, 01-01, Volume: 636 Topics: Adult; Aged; Aged, 80 and over; Cognition; Cognition Disorders; Female; Folic Acid; Homocysteine; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Treatment Outcome; Vitamin B 12	2017
Levodopa-related motor complications--phenomenology. Movement disorders : official journal of the Movement Disorder Society, 2008, Volume: 23 Suppl 3 Topics: Antiparkinson Agents; Cognition Disorders; Disease Progression; Drug Administration Schedule; Dyskinesias; Fatigue; Humans; Levodopa; Mood Disorders; Motor Activity; Parkinson Disease; Treatment Failure	2008
Treatment of early Parkinson's disease. Part 2. European neurology, 2009, Volume: 61, Issue:4 Topics: Antiparkinson Agents; Autonomic Nervous System Diseases; Clinical Trials as Topic; Cognition Disorders; Depression; Disruptive, Impulse Control, and Conduct Disorders; Dopamine Agonists; Humans; Levodopa; Monoamine Oxidase Inhibitors; Neuroprotective Agents; Olfaction Disorders; Pain; Parkinson Disease; Psychotic Disorders; Sleep Wake Disorders; Time Factors	2009
Hallucinations in Parkinson disease. Nature reviews. Neurology, 2009, Volume: 5, Issue:6 Topics: Animals; Antipsychotic Agents; Cholinesterase Inhibitors; Cognition Disorders; Hallucinations; Humans; Illusions; Levodopa; Magnetic Resonance Imaging; Neurotransmitter Agents; Parkinson Disease; Sleep Wake Disorders	2009
Hyperhomocysteinemia in L-dopa treated patients with Parkinson's disease: potential implications in cognitive dysfunction and dementia? Current medicinal chemistry, 2010, Volume: 17, Issue:28 Topics: Antiparkinson Agents; Cognition Disorders; Dementia; Homocysteine; Humans; Hyperhomocysteinemia; Levodopa; Neurons; Parkinson Disease	2010
The MPTP-lesioned non-human primate models of Parkinson's disease. Past, present, and future. Progress in brain research, 2010, Volume: 184 Topics: alpha-Synuclein; Animals; Antiparkinson Agents; Basal Ganglia; Cognition Disorders; Disease Models, Animal; Dopamine; Drug Discovery; Endpoint Determination; Humans; Levodopa; Movement; MPTP Poisoning; Neurons; Neuroprotective Agents; Parkinson Disease, Secondary; Primates; Psychoses, Substance-Induced; Sleep Wake Disorders	2010
Parkinson's disease therapeutics: new developments and challenges since the introduction of levodopa. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2012, Volume: 37, Issue:1 Topics: Antiparkinson Agents; Brain Tissue Transplantation; Cognition Disorders; Deep Brain Stimulation; Humans; Levodopa; Parkinson Disease	2012
Contribution of serotonergic transmission to the motor and cognitive effects of high-frequency stimulation of the subthalamic nucleus or levodopa in Parkinson's disease. Molecular neurobiology, 2012, Volume: 45, Issue:1 Topics: Animals; Antiparkinson Agents; Cognition Disorders; Deep Brain Stimulation; Humans; Levodopa; Parkinson Disease; Serotonin; Subthalamic Nucleus	2012
Functional neuroimaging in Parkinson's disease. Cold Spring Harbor perspectives in medicine, 2012, Volume: 2, Issue:5 Topics: Antiparkinson Agents; Brain Diseases, Metabolic; Cognition Disorders; Disease Progression; Dopamine; Dyskinesia, Drug-Induced; Fluorodeoxyglucose F18; Functional Neuroimaging; Humans; Levodopa; Lewy Bodies; Magnetic Resonance Imaging; Neurotransmitter Agents; Parkinson Disease; Positron-Emission Tomography; Psychomotor Disorders; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon	2012
[Rasagiline in monotherapy in patients with early stages of Parkinson's disease and in combined and adjunct therapy to levodopa with moderate and advanced stages]. Revista de neurologia, 2013, Jan-01, Volume: 56, Issue:1 Topics: Antiparkinson Agents; Attention; Clinical Trials as Topic; Cognition Disorders; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Therapy, Combination; Executive Function; Fatigue; Headache; Humans; Indans; Levodopa; Monoamine Oxidase Inhibitors; Motor Activity; Multicenter Studies as Topic; Nausea; Neuroprotective Agents; Parkinson Disease; Severity of Illness Index	2013
Dopamine and the regulation of cognition and attention. Progress in neurobiology, 2002, Volume: 67, Issue:1 Topics: Adult; Aged; Aging; Animals; Antiparkinson Agents; Attention; Attention Deficit Disorder with Hyperactivity; Autistic Disorder; Basal Ganglia; Child; Cognition; Cognition Disorders; Dopamine; Dopamine Agonists; Humans; Levodopa; Limbic System; Middle Aged; Models, Neurological; Models, Psychological; Parkinson Disease; Phylogeny; Receptors, Dopamine; Schizophrenic Psychology	2002
Differential diagnosis between early Parkinson's disease and dementia with Lewy bodies. Advances in neurology, 2003, Volume: 91 Topics: Brain; Cognition Disorders; Diagnosis, Differential; Disease Progression; Hallucinations; Humans; Levodopa; Lewy Body Disease; Mood Disorders; Parkinson Disease	2003
[Parkinson's disease]. Ryoikibetsu shokogun shirizu, 2003, Issue:40 Topics: Antidepressive Agents, Tricyclic; Anxiety Disorders; Cognition Disorders; Depressive Disorder; Humans; Levodopa; Monoamine Oxidase Inhibitors; Parkinson Disease; Risk Factors; Selective Serotonin Reuptake Inhibitors	2003
Pharmacological stimulant treatment of neurocognitive and functional deficits after traumatic and non-traumatic brain injury. Medical science monitor : international medical journal of experimental and clinical research, 2005, Volume: 11, Issue:6 Topics: Amantadine; Animals; Brain Injuries; Bromocriptine; Cognition Disorders; Dextroamphetamine; Humans; Levodopa; Methylphenidate	2005
Craniopharyngioma radiotherapy: endocrine and cognitive effects. Journal of pediatric endocrinology & metabolism : JPEM, 2006, Volume: 19 Suppl 1 Topics: Adolescent; Adult; Child; Child, Preschool; Cognition Disorders; Combined Modality Therapy; Craniopharyngioma; Dopamine Agents; Endocrine System Diseases; Female; Human Growth Hormone; Humans; Intelligence Tests; Levodopa; Male; Neuropsychological Tests; Pituitary Hormones; Pituitary Neoplasms; Radiotherapy; Treatment Outcome	2006
Neuropharmacological treatment of mental dysfunction in Parkinson's disease. Behavioural neurology, 2006, Volume: 17, Issue:1 Topics: Basal Ganglia; Cholinergic Agents; Cognition Disorders; Dopamine Agonists; Frontal Lobe; Humans; Levodopa; Mood Disorders; Norepinephrine; Parkinson Disease	2006
Treatment of advanced Parkinson's disease. Expert review of neurotherapeutics, 2006, Volume: 6, Issue:8 Topics: Antiparkinson Agents; Autonomic Nervous System Diseases; Cognition Disorders; Humans; Levodopa; Mental Disorders; Parkinson Disease; Sleep Wake Disorders	2006
[Drug treatment for geriatric urinary disorders; current concept]. Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics, 2006, Volume: 43, Issue:4 Topics: Aged; Aged, 80 and over; Amantadine; Cerebral Infarction; Cholinergic Antagonists; Cognition Disorders; Deamino Arginine Vasopressin; Diagnosis, Differential; Donepezil; Humans; Indans; Levodopa; Piperidines; Quality of Life; Serotonin Agents; Urination Disorders	2006
[Clinical criteria of Parkinson's disease]. Therapeutische Umschau. Revue therapeutique, 2007, Volume: 64, Issue:1 Topics: Age Factors; Aged; Antiparkinson Agents; Cognition Disorders; Dementia; Diagnosis, Differential; Dopamine Agonists; Humans; Levodopa; Middle Aged; Parkinson Disease; Positron-Emission Tomography; Risk Factors; Time Factors; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed	2007
The relationship of Parkinson disease with aging. Archives of neurology, 2007, Volume: 64, Issue:9 Topics: Aging; Antiparkinson Agents; Cognition Disorders; Dementia; Disease Progression; Gait; Humans; Levodopa; Parkinson Disease; Posture	2007
Parkinson's disease. Journal of neurology, neurosurgery, and psychiatry, 1994, Volume: 57, Issue:6 Topics: Cognition Disorders; Disabled Persons; Gait; Humans; Levodopa; Medical Audit; Movement Disorders; Neurocognitive Disorders; Neurosurgery; Parkinson Disease; Postural Balance; Practice Guidelines as Topic; Speech Disorders	1994
Treatment options for early Parkinson's disease. American family physician, 1996, Volume: 53, Issue:4 Topics: Algorithms; Amantadine; Antiparkinson Agents; Cholinergic Antagonists; Cognition Disorders; Dopamine Agonists; Humans; Levodopa; Neuroprotective Agents; Parkinson Disease; Selegiline	1996
Problems with current pharmacologic treatment of Parkinson's disease. Experimental neurology, 1997, Volume: 144, Issue:1 Topics: Antiparkinson Agents; Cognition Disorders; Disease Progression; Humans; Levodopa; Movement Disorders; Parkinson Disease; Posture	1997
Problems with long-term levodopa therapy for Parkinson's disease. Clinical neuropharmacology, 1994, Volume: 17 Suppl 2 Topics: Cognition Disorders; Dyskinesia, Drug-Induced; Gait; Humans; Levodopa; Parkinson Disease; Speech Disorders; Time Factors	1994
Managing late complications of Parkinson's disease. The Medical clinics of North America, 1999, Volume: 83, Issue:2 Topics: Cognition Disorders; Disease Progression; Dopamine Agents; Gait; Humans; Levodopa; Parkinson Disease; Treatment Outcome	1999
Role of dopamine in learning and memory: implications for the treatment of cognitive dysfunction in patients with Parkinson's disease. Drugs & aging, 2000, Volume: 16, Issue:5 Topics: Animals; Cognition; Cognition Disorders; Dopamine; Humans; Levodopa; Memory; Parkinson Disease; Prefrontal Cortex	2000
Dementia with Lewy bodies: clinical features and treatment. Drugs & aging, 2001, Volume: 18, Issue:6 Topics: Aged; Antiparkinson Agents; Antipsychotic Agents; Cholinesterase Inhibitors; Cognition Disorders; Diagnosis, Differential; Humans; Levodopa; Lewy Body Disease; Middle Aged; Motor Activity	2001
Parkinson's disease: medical treatment of moderate to advanced disease. Current neurology and neuroscience reports, 2002, Volume: 2, Issue:4 Topics: Amantadine; Anti-Anxiety Agents; Antidepressive Agents; Antiparkinson Agents; Antipsychotic Agents; Catechol O-Methyltransferase; Catechol O-Methyltransferase Inhibitors; Cholinergic Antagonists; Cognition Disorders; Disease Progression; Dopamine Agonists; Humans; Levodopa; Neuroprotective Agents; Parkinson Disease	2002
[Parkinson's disease: some physiopathologic aspects and clinical practice]. La Revue du praticien, 1989, Mar-09, Volume: 39, Issue:8 Topics: Cognition Disorders; Dopamine; Dopamine Agents; Humans; Levodopa; Motor Activity; Neurons; Parkinson Disease; Substantia Nigra	1989

Trials

27 trial(s) available for levodopa and Cognition Disorders

Article	Year
Efficacy and safety of rasagiline as an adjunct to levodopa treatment in Chinese patients with Parkinson's disease: a randomized, double-blind, parallel-controlled, multi-centre trial. The international journal of neuropsychopharmacology, 2013, Volume: 16, Issue:7 Topics: Adult; Aged; Antiparkinson Agents; Asian People; Cognition Disorders; Disease Progression; Double-Blind Method; Female; Humans; Indans; Levodopa; Male; Middle Aged; Neuroprotective Agents; Parkinson Disease	2013
Relation of lead trajectory and electrode position to neuropsychological outcomes of subthalamic neurostimulation in Parkinson's disease: results from a randomized trial. Brain : a journal of neurology, 2013, Volume: 136, Issue:Pt 7 Topics: Aged; Antiparkinson Agents; Caudate Nucleus; Cognition Disorders; Deep Brain Stimulation; Double-Blind Method; Electrodes; Female; Functional Laterality; Globus Pallidus; Humans; Lead; Levodopa; Magnetic Resonance Imaging; Male; Middle Aged; Neuropsychological Tests; Outcome Assessment, Health Care; Parkinson Disease; Statistics, Nonparametric; Subthalamic Nucleus	2013
AFQ056 in Parkinson patients with levodopa-induced dyskinesia: 13-week, randomized, dose-finding study. Movement disorders : official journal of the Movement Disorder Society, 2013, Volume: 28, Issue:13 Topics: Aged; Antiparkinson Agents; Cognition Disorders; Dose-Response Relationship, Drug; Double-Blind Method; Dyskinesia, Drug-Induced; Female; Follow-Up Studies; Humans; Indoles; International Cooperation; Levodopa; Male; Middle Aged; Outcome Assessment, Health Care; Parkinson Disease; Psychiatric Status Rating Scales; Severity of Illness Index; Time Factors	2013
Two-year follow-up on the effect of unilateral subthalamic deep brain stimulation in highly asymmetric Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 2009, Feb-15, Volume: 24, Issue:3 Topics: Aged; Antiparkinson Agents; Cognition Disorders; Combined Modality Therapy; Deep Brain Stimulation; Drug Resistance; Female; Follow-Up Studies; Functional Laterality; Humans; Hypokinesia; Levodopa; Male; Middle Aged; Neuropsychological Tests; Parkinson Disease; Postoperative Care; Posture; Preoperative Care; Severity of Illness Index; Subthalamic Nucleus; Surveys and Questionnaires; Time Factors; Tremor	2009
New approach to the rehabilitation of post-stroke focal cognitive syndrome: effect of levodopa combined with speech and language therapy on functional recovery from aphasia. Journal of the neurological sciences, 2009, Aug-15, Volume: 283, Issue:1-2 Topics: Adult; Aged; Aphasia; Cognition Disorders; Combined Modality Therapy; Dopamine Agents; Double-Blind Method; Female; Humans; Language Tests; Language Therapy; Levodopa; Male; Middle Aged; Prospective Studies; Recovery of Function; Speech Therapy; Stroke; Stroke Rehabilitation; Syndrome; Treatment Outcome	2009
Longitudinal study of the levodopa motor response in Parkinson's disease: relationship between cognitive decline and motor function. Movement disorders : official journal of the Movement Disorder Society, 2009, Dec-15, Volume: 24, Issue:16 Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Antiparkinson Agents; Cognition Disorders; Dementia; Disability Evaluation; Dyskinesias; Female; Humans; Levodopa; Longitudinal Studies; Male; Middle Aged; Motor Activity; Parkinsonian Disorders; Statistics, Nonparametric	2009
Use of memantine (akatinol) for the correction of cognitive impairments in Parkinson's disease complicated by dementia. Neuroscience and behavioral physiology, 2010, Volume: 40, Issue:2 Topics: Activities of Daily Living; Aged; Antiparkinson Agents; Cognition; Cognition Disorders; Dementia; Disability Evaluation; Dyskinesias; Homocysteine; Humans; Levodopa; Memantine; Neuropsychological Tests; Nootropic Agents; Parkinson Disease; Psychiatric Status Rating Scales; Receptors, N-Methyl-D-Aspartate; Treatment Outcome	2010
Dopaminergic modulation of rapid reality adaptation in thinking. Neuroscience, 2010, May-19, Volume: 167, Issue:3 Topics: Adaptation, Psychological; Adult; Brain; Cognition Disorders; Dopamine; Dopamine Agents; Dopamine Antagonists; Double-Blind Method; Humans; Levodopa; Male; Memory; Memory Disorders; Mental Processes; Neural Inhibition; Neuropsychological Tests; Psychoses, Substance-Induced; Risperidone	2010
Long-term stability of effects of subthalamic stimulation in Parkinson's disease: Indian Experience. Movement disorders : official journal of the Movement Disorder Society, 2010, Oct-30, Volume: 25, Issue:14 Topics: Adult; Antiparkinson Agents; Attention; Cognition Disorders; Deep Brain Stimulation; Dyskinesias; Executive Function; Female; Humans; India; Levodopa; Longitudinal Studies; Male; Middle Aged; Neuropsychological Tests; Parkinson Disease; Quality of Life; Retrospective Studies; Single-Blind Method; Subthalamic Nucleus; Time Factors; Treatment Outcome	2010
Impulse control disorders in Parkinson disease: a multicenter case--control study. Annals of neurology, 2011, Volume: 69, Issue:6 Topics: Aged; Analysis of Variance; Antiparkinson Agents; Case-Control Studies; Cognition Disorders; Cross-Sectional Studies; Disability Evaluation; Disruptive, Impulse Control, and Conduct Disorders; Dopamine Agonists; Female; Humans; Levodopa; Male; Middle Aged; Neuropsychological Tests; Parkinson Disease; Psychiatric Status Rating Scales	2011
Effect of methylphenidate and/or levodopa combined with physiotherapy on mood and cognition after stroke: a randomized, double-blind, placebo-controlled trial. European neurology, 2011, Volume: 66, Issue:1 Topics: Aged; Analysis of Variance; Antiparkinson Agents; Central Nervous System Stimulants; Cognition Disorders; Double-Blind Method; Female; Humans; Levodopa; Male; Methylphenidate; Middle Aged; Mood Disorders; Neuropsychological Tests; Physical Therapy Modalities; Psychiatric Status Rating Scales; Retrospective Studies; Stroke; Time Factors; Treatment Outcome	2011
Levodopa medication does not influence motor inhibition or conflict resolution in a conditional stop-signal task in Parkinson's disease. Experimental brain research, 2011, Volume: 213, Issue:4 Topics: Aged; Antiparkinson Agents; Cognition Disorders; Disability Evaluation; Executive Function; Female; Humans; Levodopa; Male; Middle Aged; Neural Inhibition; Parkinson Disease	2011
Pramipexole in comparison to l-dopa: a neuropsychological study. Journal of neural transmission (Vienna, Austria : 1996), 2003, Volume: 110, Issue:4 Topics: Aged; Analysis of Variance; Benzothiazoles; Cognition Disorders; Female; Humans; Levodopa; Male; Middle Aged; Neuropsychological Tests; Parkinson Disease; Pramipexole; Thiazoles	2003
Cognitive performance in people with Parkinson's disease and mild or moderate depression: effects of dopamine agonists in an add-on to L-dopa therapy. European journal of neurology, 2005, Volume: 12, Issue:1 Topics: Aged; Analysis of Variance; Cognition Disorders; Depression; Dopamine Agonists; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Prospective Studies; Statistics, Nonparametric	2005
Psychometric schizotypy modulates levodopa effects on lateralized lexical decision performance. Journal of psychiatric research, 2005, Volume: 39, Issue:3 Topics: Adult; Brain; Cognition Disorders; Dopamine; Dopamine Agonists; Double-Blind Method; Functional Laterality; Humans; Language; Levodopa; Male; Psychometrics; Schizotypal Personality Disorder; Semantics; Surveys and Questionnaires; Thinking	2005
Comparison of age of onset and development of motor complications between smokers and non-smokers in Parkinson's disease. Journal of the neurological sciences, 2005, Apr-15, Volume: 231, Issue:1-2 Topics: Age of Onset; Aged; Antiparkinson Agents; Case-Control Studies; Cognition Disorders; Cohort Studies; Dyskinesia, Drug-Induced; Female; Human Development; Humans; Levodopa; Male; Middle Aged; Movement Disorders; Parkinson Disease; Smoking; Time Factors	2005
Effect of repetitive TMS and fluoxetine on cognitive function in patients with Parkinson's disease and concurrent depression. Movement disorders : official journal of the Movement Disorder Society, 2005, Volume: 20, Issue:9 Topics: Aged; Antiparkinson Agents; Cognition Disorders; Depressive Disorder, Major; Double-Blind Method; Female; Fluoxetine; Functional Laterality; Humans; Levodopa; Male; Neuropsychological Tests; Parkinson Disease; Periodicity; Prefrontal Cortex; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Transcranial Magnetic Stimulation	2005
Effect of levodopa on cognitive function in Parkinson's disease with and without dementia and dementia with Lewy bodies. Journal of neurology, neurosurgery, and psychiatry, 2006, Volume: 77, Issue:12 Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Attention; Cognition; Cognition Disorders; Female; Humans; Levodopa; Lewy Body Disease; Male; Motor Skills; Parkinson Disease; Treatment Outcome	2006
Risk factors for somnolence, edema, and hallucinations in early Parkinson disease. Neurology, 2007, Jul-10, Volume: 69, Issue:2 Topics: Adult; Age Distribution; Antiparkinson Agents; Benzothiazoles; Cognition Disorders; Cohort Studies; Comorbidity; Disorders of Excessive Somnolence; Double-Blind Method; Edema; Female; Hallucinations; Heart Diseases; Humans; Levodopa; Male; Middle Aged; Neuropsychological Tests; Parkinson Disease; Pramipexole; Risk Factors; Sex Distribution	2007
Dopaminergic effects on cognitive performance in patients with Parkinson's disease. Journal of neural transmission. Supplementum, 1995, Volume: 46 Topics: Aged; Antiparkinson Agents; Brain; Cognition Disorders; Dopamine; Dopamine Agents; Female; Frontal Lobe; Humans; Levodopa; Male; Memory; Middle Aged; Neuropsychological Tests; Parkinson Disease	1995
Acute and long-term administration of anticholinergics in Parkinson's disease: specific effects on the subcortico-frontal syndrome. Brain and cognition, 1999, Volume: 40, Issue:2 Topics: Acute Disease; Cholinergic Antagonists; Cognition Disorders; Corpus Striatum; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Humans; Levodopa; Middle Aged; Nerve Degeneration; Neuropsychological Tests; Parkinson Disease; Scopolamine; Severity of Illness Index; Substantia Nigra; Syndrome; Time Factors; Trihexyphenidyl	1999
Effects of unilateral posteroventral pallidotomy on 'on-off' cognitive fluctuations in Parkinson's disease. Neuropsychologia, 2000, Volume: 38, Issue:5 Topics: Aged; Antiparkinson Agents; Cognition Disorders; Female; Functional Laterality; Globus Pallidus; Humans; Levodopa; Magnetic Resonance Imaging; Male; Middle Aged; Neuropsychological Tests; Parkinson Disease; Tomography, X-Ray Computed	2000
Chronic effects of dopaminergic replacement on cognitive function in Parkinson's disease: a two-year follow-up study of previously untreated patients. Movement disorders : official journal of the Movement Disorder Society, 2000, Volume: 15, Issue:4 Topics: Aged; Antiparkinson Agents; Cognition Disorders; Dopamine Agents; Drug Therapy, Combination; Female; Follow-Up Studies; Frontal Lobe; Humans; Levodopa; Male; Middle Aged; Motor Skills; Neuropsychological Tests; Parkinson Disease; Pergolide	2000
Levodopa treatment of presenile dementia. Acta psychiatrica Scandinavica, 1977, Volume: 55, Issue:1 Topics: Adult; Cognition Disorders; Dementia; Drug Evaluation; Female; Humans; Levodopa; Male; Memory Disorders; Middle Aged; Neuropsychological Tests; Parkinson Disease; Psychiatric Status Rating Scales; Wechsler Scales	1977
Different effects of dopaminergic and anticholinergic therapies on cognitive and motor function in Parkinson's disease. A follow-up study of untreated patients. Brain : a journal of neurology, 1992, Volume: 115 ( Pt 6) Topics: Adult; Aged; Bromocriptine; Cognition Disorders; Female; Follow-Up Studies; Frontal Lobe; Humans; Levodopa; Male; Memory Disorders; Middle Aged; Motor Activity; Movement; Parasympatholytics; Parkinson Disease; Psychomotor Performance; Visual Perception	1992
L-dopa withdrawal in Parkinson's disease selectively impairs cognitive performance in tests sensitive to frontal lobe dysfunction. Psychopharmacology, 1992, Volume: 107, Issue:2-3 Topics: Brain Diseases; Cognition Disorders; Discrimination, Psychological; Female; Frontal Lobe; Humans; Learning; Levodopa; Male; Memory; Middle Aged; Parkinson Disease; Psychomotor Performance; Substance Withdrawal Syndrome	1992
Cognitive enhancement in Korsakoff's psychosis by clonidine: a comparison with L-dopa and ephedrine. Psychopharmacology, 1986, Volume: 88, Issue:3 Topics: Alcohol Amnestic Disorder; Attention; Biogenic Amines; Brain Chemistry; Clonidine; Cognition Disorders; Ephedrine; Humans; Levodopa; Male; Memory; Methoxyhydroxyphenylglycol; Perception; Psychomotor Performance	1986

Other Studies

121 other study(ies) available for levodopa and Cognition Disorders

Article	Year
Personality, dopamine, and Parkinson's disease: Insights from subthalamic stimulation. Movement disorders : official journal of the Movement Disorder Society, 2017, Volume: 32, Issue:8 Topics: Adult; Aged; Antiparkinson Agents; Cognition Disorders; Deep Brain Stimulation; Dopamine; Female; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Neuropsychological Tests; Parkinson Disease; Personality; Statistics, Nonparametric; Subthalamic Nucleus; Surveys and Questionnaires	2017
Inhibitory control is not lateralized in Parkinson's patients. Neuropsychologia, 2017, Jul-28, Volume: 102 Topics: Aged; Analysis of Variance; Antiparkinson Agents; Case-Control Studies; Cognition Disorders; Female; Functional Laterality; Humans; Inhibition, Psychological; Levodopa; Male; Middle Aged; Parkinson Disease; Photic Stimulation; Reaction Time	2017
Role of estrogen and levodopa in 1-methyl-4-pheny-l-1, 2, 3, 6-tetrahydropyridine (mptp)-induced cognitive deficit in Parkinsonian ovariectomized mice model: A comparative study. Journal of chemical neuroanatomy, 2017, Volume: 85 Topics: Acetylcholinesterase; Animals; Cognition Disorders; Dopaminergic Neurons; Estradiol; Levodopa; Maze Learning; Mice; MPTP Poisoning; Neuroprotective Agents; Ovariectomy; Substantia Nigra; Tyrosine 3-Monooxygenase	2017
Correlations Between Methionine Cycle Metabolism, COMT Genotype, and Polyneuropathy in L-Dopa Treated Parkinson's Disease: A Preliminary Cross-Sectional Study. Journal of Parkinson's disease, 2017, Volume: 7, Issue:4 Topics: Aged; Catechol O-Methyltransferase; Cognition Disorders; Cross-Sectional Studies; Female; Genotype; Homocysteine; Humans; Levodopa; Male; Methionine; Middle Aged; Neuropsychological Tests; Parkinson Disease; Polymorphism, Single Nucleotide; Polyneuropathies; Statistics, Nonparametric; Vitamins	2017
Dopaminergic Effect on Non-Motor Symptoms in Late Stage Parkinson's Disease. Journal of Parkinson's disease, 2018, Volume: 8, Issue:3 Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Cognition Disorders; Dopamine Agents; Fatigue; Female; Humans; Levodopa; Male; Mood Disorders; Parkinson Disease; Treatment Outcome	2018
An mGlu4-Positive Allosteric Modulator Alleviates Parkinsonism in Primates. Movement disorders : official journal of the Movement Disorder Society, 2018, Volume: 33, Issue:10 Topics: Allosteric Regulation; Animals; Antiparkinson Agents; Cognition Disorders; Disease Models, Animal; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Excitatory Amino Acid Antagonists; Levodopa; Macaca fascicularis; Parkinsonian Disorders; Positron-Emission Tomography; Receptors, Metabotropic Glutamate; Time Factors	2018
SPG11-related parkinsonism: Clinical profile, molecular imaging and l-dopa response. Movement disorders : official journal of the Movement Disorder Society, 2018, Volume: 33, Issue:10 Topics: Adult; Antiparkinson Agents; Brain; Cognition Disorders; Cohort Studies; Dopamine Plasma Membrane Transport Proteins; Female; Humans; Levodopa; Male; Mental Disorders; Middle Aged; Mutation; Neuropsychological Tests; Organotechnetium Compounds; Parkinsonian Disorders; Proteins; Single-Blind Method; Statistics, Nonparametric; Tomography Scanners, X-Ray Computed; Tomography, Emission-Computed, Single-Photon; Tropanes; Young Adult	2018
Relationship between cognitive impairment and white-matter alteration in Parkinson's disease with dementia: tract-based spatial statistics and tract-specific analysis. European radiology, 2013, Volume: 23, Issue:7 Topics: Aged; Anisotropy; Brain; Brain Mapping; Case-Control Studies; Cognition; Cognition Disorders; Corpus Callosum; Dementia; Diffusion Tensor Imaging; Female; Humans; Levodopa; Male; Mental Status Schedule; Middle Aged; Nerve Fibers, Myelinated; Parkinson Disease	2013
Levodopa-resistant freezing of gait and executive dysfunction in Parkinson's disease. European neurology, 2013, Volume: 69, Issue:5 Topics: Aged; Antiparkinson Agents; Cognition Disorders; Deep Brain Stimulation; Executive Function; Female; Gait Disorders, Neurologic; Humans; Levodopa; Male; Middle Aged; Neuropsychological Tests; Parkinson Disease; Prospective Studies; Retrospective Studies; Severity of Illness Index; Subthalamic Nucleus	2013
Mutation in the SYNJ1 gene associated with autosomal recessive, early-onset Parkinsonism. Human mutation, 2013, Volume: 34, Issue:9 Topics: Adolescent; Adult; Age of Onset; Auxilins; Child; Cognition Disorders; Consanguinity; Dystonia; Exome; Female; Genes, Recessive; Genetic Variation; Homozygote; Humans; Italy; Levodopa; Male; Middle Aged; Mutation; Parkinsonian Disorders; Pedigree; Phosphoric Monoester Hydrolases; Radiography; Sequence Analysis, DNA; Young Adult	2013
The timing between REM sleep behavior disorder and Parkinson's disease. Sleep & breathing = Schlaf & Atmung, 2014, Volume: 18, Issue:2 Topics: Aged; Cognition Disorders; Disease Progression; Dopamine Agents; Dose-Response Relationship, Drug; Electromyography; Female; Humans; Levodopa; Male; Mental Status Schedule; Middle Aged; Parkinson Disease; Polysomnography; REM Sleep Behavior Disorder; Time Factors	2014
Vascular parkinsonism: a case series of 17 patients. Arquivos de neuro-psiquiatria, 2013, Volume: 71, Issue:10 Topics: Activities of Daily Living; Aged; Aged, 80 and over; Antiparkinson Agents; Cerebrovascular Disorders; Cognition Disorders; Cross-Sectional Studies; Female; Humans; Hypertension; Levodopa; Male; Parkinson Disease, Secondary; Risk Factors; Surveys and Questionnaires; Treatment Outcome	2013
Dopamine receptor dysregulation in hippocampus of aged rats underlies chronic pulsatile L-Dopa treatment induced cognitive and emotional alterations. Neuropharmacology, 2014, Volume: 82 Topics: Age Factors; Anhedonia; Animals; Antiparkinson Agents; Behavior, Animal; Carbidopa; Cognition Disorders; Drug Combinations; Emotions; Hippocampus; Levodopa; Male; Mental Disorders; Motor Activity; Neurons; Rats, Wistar; Receptors, Dopamine; Receptors, Dopamine D2; Receptors, Dopamine D3; Receptors, Dopamine D5; Spatial Learning	2014
[Treatment & management guidelines 2011 for Parkinson disease]. Rinsho shinkeigaku = Clinical neurology, 2013, Volume: 53, Issue:11 Topics: Antiparkinson Agents; Cognition Disorders; Depression; Dopamine Agonists; Drug Administration Schedule; Humans; Japan; Levodopa; Movement Disorders; Neurology; Parkinson Disease; Practice Guidelines as Topic; Societies, Medical	2013
Deleterious cognitive and motoric effects of haloperidol in an adolescent with cerebral palsy: a case report. PM & R : the journal of injury, function, and rehabilitation, 2013, Volume: 5, Issue:12 Topics: Adolescent; Amantadine; Carbidopa; Cerebral Palsy; Cognition Disorders; Dopamine Agonists; Dopamine Antagonists; Drug Combinations; Haloperidol; Humans; Levodopa; Male; Psychomotor Disorders	2013
Long-term levodopa/carbidopa intestinal gel in advanced Parkinson's disease. Journal of neurology, 2014, Volume: 261, Issue:3 Topics: Aged; Antiparkinson Agents; Carbidopa; Cognition Disorders; Cognitive Dysfunction; Disease Progression; Drug Combinations; Female; Follow-Up Studies; Gastrostomy; Gels; Humans; Infusions, Parenteral; Levodopa; Male; Middle Aged; Neuropsychological Tests; Parkinson Disease; Severity of Illness Index; Treatment Outcome	2014
Progression of gait dysfunction in incident Parkinson's disease: impact of medication and phenotype. Movement disorders : official journal of the Movement Disorder Society, 2015, Volume: 30, Issue:3 Topics: Aged; Cognition Disorders; Cohort Studies; Disability Evaluation; Disease Progression; Dopamine Agents; Female; Gait Disorders, Neurologic; Humans; Incidence; Levodopa; Male; Middle Aged; Neuropsychological Tests; Parkinson Disease; Phenotype; Walking	2015
Paradoxical effect of dopamine medication on cognition in Parkinson's disease: relationship to side of motor onset. Journal of the International Neuropsychological Society : JINS, 2015, Volume: 21, Issue:4 Topics: Aged; Attention; Cognition Disorders; Dopamine Agonists; Executive Function; Female; Functional Laterality; Humans; Levodopa; Male; Mental Status Schedule; Middle Aged; Motor Activity; Multivariate Analysis; Neuropsychological Tests; Parkinson Disease; Psychomotor Performance; Severity of Illness Index; Space Perception; Verbal Learning	2015
Subthalamic nucleus activity in the awake hemiparkinsonian rat: relationships with motor and cognitive networks. The Journal of neuroscience : the official journal of the Society for Neuroscience, 2015, Apr-29, Volume: 35, Issue:17 Topics: Action Potentials; Adrenergic Agents; Animals; Antiparkinson Agents; Benzazepines; Cognition Disorders; Disease Models, Animal; Dopamine Antagonists; Evoked Potentials; Functional Laterality; Levodopa; Male; Motor Activity; Oxidopamine; Parkinsonian Disorders; Rats; Rats, Long-Evans; Subthalamic Nucleus; Time Factors; Tyrosine 3-Monooxygenase; Wakefulness	2015
Parkinsonism and cognitive impairment due to a giant frontal arachnoid cyst and improving after shunting. Acta neurologica Belgica, 2017, Volume: 117, Issue:1 Topics: Aged; Antiparkinson Agents; Arachnoid Cysts; Cerebrospinal Fluid Shunts; Cognition Disorders; Female; Humans; Levodopa; Mental Status Schedule; Parkinsonian Disorders; Postoperative Complications; Tomography Scanners, X-Ray Computed	2017
A Novel Homozygous p.L539F Mutation Identified in PINK1 Gene in a Moroccan Patient with Parkinsonism. BioMed research international, 2016, Volume: 2016 Topics: Amino Acid Motifs; Chromosomes; Cognition Disorders; Computational Biology; Disease Progression; Exons; Homozygote; Humans; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Levodopa; Male; Middle Aged; Morocco; Mutation; Mutation, Missense; Oligonucleotide Array Sequence Analysis; Parkinson Disease; Pedigree; Phenotype; Protein Domains; Protein Kinases; Sequence Analysis, DNA	2016
An evaluation of istradefylline treatment on Parkinsonian motor and cognitive deficits in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated macaque models. Neuropharmacology, 2016, Volume: 110, Issue:Pt A Topics: Adenosine A2 Receptor Antagonists; Animals; Cognition Disorders; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Hypokinesia; Levodopa; Macaca fascicularis; Motor Skills Disorders; MPTP Poisoning; Purines; Treatment Outcome	2016
Pallidal stimulation in Parkinson's patients with contraindications to subthalamic target: A 3 years follow-up. Parkinsonism & related disorders, 2017, Volume: 34 Topics: Aged; Antiparkinson Agents; Cognition Disorders; Contraindications; Deep Brain Stimulation; Dyskinesia, Drug-Induced; Female; Globus Pallidus; Humans; Levodopa; Longitudinal Studies; Male; Middle Aged; Neuropsychological Tests; Neurosurgery; Parkinson Disease; Quality of Life; Severity of Illness Index; Subthalamic Nucleus; Time Factors; Treatment Outcome; Visual Analog Scale	2017
Hallucinations, dreaming, and frequent dozing in Parkinson disease: impact of right-hemisphere neural networks. Cognitive and behavioral neurology : official journal of the Society for Behavioral and Cognitive Neurology, 2008, Volume: 21, Issue:3 Topics: Aged; Antiparkinson Agents; Brain; Cognition Disorders; Disorders of Excessive Somnolence; Dreams; Female; Functional Laterality; Hallucinations; Humans; Levodopa; Male; Nerve Net; Neuropsychological Tests; Parkinson Disease; Sleep, REM	2008
A neurocomputational model of tonic and phasic dopamine in action selection: a comparison with cognitive deficits in Parkinson's disease. Behavioural brain research, 2009, Jun-08, Volume: 200, Issue:1 Topics: Analysis of Variance; Animals; Antiparkinson Agents; Brain; Cognition Disorders; Computer Simulation; Dopamine; Humans; Levodopa; Models, Neurological; Neural Networks, Computer; Neural Pathways; Neurons; Parkinson Disease; Reward	2009
A decision tool to support appropriate referral for deep brain stimulation in Parkinson's disease. Journal of neurology, 2009, Volume: 256, Issue:1 Topics: Age Factors; Aged; Cognition Disorders; Deep Brain Stimulation; Female; Humans; Levodopa; Logistic Models; Male; Middle Aged; Parkinson Disease; Referral and Consultation	2009
Medical treatment of Parkinson disease. Neurologic clinics, 2009, Volume: 27, Issue:3 Topics: Amantadine; Antiparkinson Agents; Catechol O-Methyltransferase Inhibitors; Cognition Disorders; Corpus Striatum; Digestive System Physiological Phenomena; Dopamine Agonists; Enzyme Inhibitors; Humans; Hypotension, Orthostatic; Levodopa; Mental Disorders; Monoamine Oxidase Inhibitors; Motor Activity; Movement Disorders; Neurons; Parkinson Disease; Sleep Wake Disorders; Substantia Nigra	2009
Brain dopaminergic modulation associated with executive function in Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 2009, Oct-15, Volume: 24, Issue:13 Topics: Aged; Antiparkinson Agents; Brain; Brain Mapping; Cognition Disorders; Dopamine; Executive Function; Female; Humans; Image Processing, Computer-Assisted; Levodopa; Magnetic Resonance Imaging; Male; Middle Aged; Neuropsychological Tests; Oxygen; Parkinson Disease	2009
Nonmotor symptoms in de novo Parkinson disease before and after dopaminergic treatment. Journal of the neurological sciences, 2009, Dec-15, Volume: 287, Issue:1-2 Topics: Aged; Antiparkinson Agents; Benzothiazoles; Cognition Disorders; Comorbidity; Disability Evaluation; Dopamine Agonists; Female; Gastrointestinal Diseases; Humans; Indoles; Levodopa; Male; Memory Disorders; Middle Aged; Mood Disorders; Movement Disorders; Neurologic Examination; Nocturia; Outcome Assessment, Health Care; Parkinson Disease; Pramipexole; Prevalence; Restless Legs Syndrome; Treatment Outcome	2009
Effect of the additional noradrenergic neurodegeneration to 6-OHDA-lesioned rats in levodopa-induced dyskinesias and in cognitive disturbances. Journal of neural transmission (Vienna, Austria : 1996), 2009, Volume: 116, Issue:10 Topics: Animals; Benzylamines; Cognition Disorders; Dyskinesia, Drug-Induced; Levodopa; Locus Coeruleus; Male; Maze Learning; Medial Forebrain Bundle; Memory, Short-Term; Motor Activity; Neurodegenerative Diseases; Oxidopamine; Rats; Rats, Sprague-Dawley; Severity of Illness Index; Substantia Nigra; Time Factors	2009
Decision-making impairment in a patient with new concomitant diagnoses of Parkinson's disease and HIV. The Journal of neuropsychiatry and clinical neurosciences, 2009,Summer, Volume: 21, Issue:3 Topics: Antiparkinson Agents; Brain; Cognition Disorders; Decision Making; Diagnosis, Differential; HIV Infections; Humans; Levodopa; Male; Middle Aged; Neuropsychological Tests; Parkinson Disease; Radionuclide Imaging; Treatment Outcome	2009
Conjugal Parkinsonism and Parkinson disease: a case series with environmental risk factor analysis. Parkinsonism & related disorders, 2010, Volume: 16, Issue:3 Topics: Age of Onset; Aged; Cognition Disorders; Disease Progression; Environment; Environmental Exposure; Female; Humans; Levodopa; Male; Marriage; Middle Aged; Parkinsonian Disorders; Retrospective Studies; Risk Assessment; Risk Factors; Surveys and Questionnaires	2010
Cognitive improvement after duodenal levodopa infusion in cognitively impaired Parkinson's disease patients. Progress in neuro-psychopharmacology & biological psychiatry, 2010, Feb-01, Volume: 34, Issue:1 Topics: Aged; Antiparkinson Agents; Cognition Disorders; Duodenum; Female; Humans; Levodopa; Male; Parkinson Disease	2010
Anxiety disorders in Parkinson's disease: prevalence and risk factors. Movement disorders : official journal of the Movement Disorder Society, 2010, May-15, Volume: 25, Issue:7 Topics: Aged; Antiparkinson Agents; Anxiety Disorders; Cognition Disorders; Comorbidity; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Female; Functional Laterality; Gait; Humans; Levodopa; Male; Middle Aged; Neuropsychological Tests; Parkinson Disease; Posture; Prevalence; Risk Factors; Severity of Illness Index	2010
Juvenile levodopa-responsive Parkinsonism with early orobuccolingual dyskinesias and cognitive impairment. Movement disorders : official journal of the Movement Disorder Society, 2010, Sep-15, Volume: 25, Issue:12 Topics: Adolescent; Brain; Cognition Disorders; Deep Brain Stimulation; Dyskinesia, Drug-Induced; Female; Humans; Intranuclear Inclusion Bodies; Levodopa; Magnetic Resonance Imaging; Neurodegenerative Diseases; Parkinsonian Disorders; Young Adult	2010
Clinical features associated with REM sleep behavior disorder symptoms in the early stages of Parkinson's disease. Journal of neurology, 2011, Volume: 258, Issue:1 Topics: Aged; Antiparkinson Agents; Cognition Disorders; Diagnostic and Statistical Manual of Mental Disorders; Disability Evaluation; Disease Progression; Female; Hallucinations; Humans; Levodopa; Male; Movement; Parkinson Disease; Polysomnography; Prognosis; REM Sleep Behavior Disorder; Surveys and Questionnaires; Tremor	2011
Pharmacological characterization of MRZ-8676, a novel negative allosteric modulator of subtype 5 metabotropic glutamate receptors (mGluR5): focus on L: -DOPA-induced dyskinesia. Journal of neural transmission (Vienna, Austria : 1996), 2011, Volume: 118, Issue:12 Topics: Adrenergic Agents; Allosteric Regulation; Analysis of Variance; Animals; Brain; Calcium; Cognition Disorders; Conditioning, Psychological; Disease Models, Animal; Dopamine Agents; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Excitatory Amino Acid Antagonists; Fear; In Vitro Techniques; Levodopa; Male; Maze Learning; Microdialysis; Monoamine Oxidase Inhibitors; Motor Activity; Oxidopamine; Pain Measurement; Parkinson Disease, Secondary; Picolinic Acids; Psychomotor Performance; Quinolones; Rats; Rats, Sprague-Dawley; Receptor, Metabotropic Glutamate 5; Receptors, Metabotropic Glutamate; Rotarod Performance Test; Tandem Mass Spectrometry; Time Factors	2011
Transient executive dysfunction following STNDBS in Parkinson's disease. The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques, 2011, Volume: 38, Issue:2 Topics: Aged; Antiparkinson Agents; Carbidopa; Cognition Disorders; Deep Brain Stimulation; Executive Function; Female; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Neuropsychological Tests; Parkinson Disease; Subthalamic Nucleus; Time Factors	2011
Factors associated with cognitive impairment in patients with Parkinson disease: an urban study. La Clinica terapeutica, 2011, Volume: 162, Issue:1 Topics: Activities of Daily Living; Adult; Age of Onset; Aged; Aged, 80 and over; Antiparkinson Agents; Caregivers; Cognition Disorders; Cross-Sectional Studies; Educational Status; Ethnicity; Female; Follow-Up Studies; Humans; Levodopa; Malaysia; Male; Middle Aged; Neuropsychological Tests; Parkinson Disease; Risk Factors; Severity of Illness Index; Surveys and Questionnaires; Urban Population	2011
Levodopa-induced breathing, cognitive and behavioral changes in Parkinson's disease. Journal of neurology, 2011, Volume: 258, Issue:12 Topics: Aged; Antiparkinson Agents; Carbidopa; Cognition Disorders; Drug Combinations; Humans; Levodopa; Male; Mental Disorders; Parkinson Disease; Respiration Disorders	2011
[Extrapyramidal symptoms due to calcinosis cerebri in a patient with unknown primary hypoparathyroidism]. Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion, 2012, Volume: 59, Issue:1 Topics: Basal Ganglia Diseases; Brain Diseases, Metabolic; Calcinosis; Calcitriol; Calcium; Cognition Disorders; Depressive Disorder; Diagnosis, Differential; Dyslipidemias; Female; Gait Disorders, Neurologic; Gluconates; Humans; Hypoparathyroidism; Levodopa; Magnesium; Middle Aged; Syndrome	2012
Network correlates of the cognitive response to levodopa in Parkinson disease. Neurology, 2011, Aug-30, Volume: 77, Issue:9 Topics: Aged; Cognition; Cognition Disorders; Female; Humans; Levodopa; Male; Middle Aged; Neuropsychological Tests; Parkinson Disease; Treatment Outcome; Verbal Learning	2011
The default mode network integrity in patients with Parkinson's disease is levodopa equivalent dose-dependent. Journal of neural transmission (Vienna, Austria : 1996), 2012, Volume: 119, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Brain; Cognition Disorders; Dose-Response Relationship, Drug; Female; Humans; Image Processing, Computer-Assisted; Levodopa; Magnetic Resonance Imaging; Male; Middle Aged; Neuropsychological Tests; Oxygen; Parkinson Disease; Photic Stimulation	2012
Combined delusional misidentification syndrome in a patient with Parkinson's disease. The Journal of neuropsychiatry and clinical neurosciences, 2012,Winter, Volume: 24, Issue:1 Topics: Aged; Antiparkinson Agents; Capgras Syndrome; Cognition Disorders; Delusions; Humans; Levodopa; Male; Parkinson Disease	2012
Motor and cognitive impairments in Parkinson disease: relationships with specific balance and mobility tasks. Neurorehabilitation and neural repair, 2013, Volume: 27, Issue:1 Topics: Adult; Antiparkinson Agents; Cognition Disorders; Female; Humans; Leg; Levodopa; Male; Mental Status Schedule; Middle Aged; Movement; Muscle Strength; Muscle, Skeletal; Parkinson Disease; Postural Balance; Predictive Value of Tests; Psychomotor Performance; Residence Characteristics; Task Performance and Analysis	2013
Long-term duodenal levodopa infusion in Parkinson's disease: a 3-year motor and cognitive follow-up study. Journal of neurology, 2013, Volume: 260, Issue:1 Topics: Adult; Aged; Antiparkinson Agents; Carbidopa; Cognition Disorders; Disability Evaluation; Drug Combinations; Duodenum; Female; Humans; Infusions, Parenteral; Levodopa; Longitudinal Studies; Male; Middle Aged; Motor Activity; Neuropsychological Tests; Parkinson Disease; Quality of Life; Statistics, Nonparametric	2013
Clinical and cognitive profiles of patients with both Parkinson's disease and essential tremor. Acta neurologica Belgica, 2013, Volume: 113, Issue:2 Topics: Aged; Aged, 80 and over; Anticonvulsants; Antiparkinson Agents; Attention; Cognition; Cognition Disorders; Essential Tremor; Executive Function; Female; Humans; Levodopa; Male; Memory; Middle Aged; Nerve Degeneration; Neuropsychological Tests; Parkinson Disease; Primidone; Space Perception	2013
Personalized medicine strategies for managing patients with parkinsonism and cognitive deficits. Metabolism: clinical and experimental, 2013, Volume: 62 Suppl 1 Topics: alpha-Synuclein; Alzheimer Disease; Antiparkinson Agents; Biomarkers; Cognition; Cognition Disorders; Diagnosis, Differential; Diagnostic Imaging; Frontotemporal Dementia; Genetic Markers; Genetic Testing; Glucosylceramidase; Humans; Huntington Disease; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Levodopa; Lewy Body Disease; Mutation; Parkinson Disease; Precision Medicine; Protein Serine-Threonine Kinases	2013
Gait patterns in Parkinsonian patients with or without mild cognitive impairment. Movement disorders : official journal of the Movement Disorder Society, 2012, Volume: 27, Issue:12 Topics: Aged; Analysis of Variance; Antiparkinson Agents; Case-Control Studies; Cognition Disorders; Executive Function; Female; Gait Disorders, Neurologic; Humans; Levodopa; Male; Memory; Middle Aged; Neurologic Examination; Neuropsychological Tests; Parkinsonian Disorders; Psychomotor Performance; Severity of Illness Index	2012
Levodopa improves motor deficits but can further disrupt cognition in a macaque Parkinson model. Movement disorders : official journal of the Movement Disorder Society, 2013, Volume: 28, Issue:5 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Analysis of Variance; Animals; Antiparkinson Agents; Cognition Disorders; Conditioning, Operant; Disease Models, Animal; Levodopa; Macaca fascicularis; Male; Movement; MPTP Poisoning; Photic Stimulation; Time Factors	2013
What helps can also hinder: a dissociation in the acute effect of levodopa treatment on motor and cognitive functions. Movement disorders : official journal of the Movement Disorder Society, 2013, Volume: 28, Issue:5 Topics: Animals; Antiparkinson Agents; Cognition Disorders; Levodopa; Male; Movement; MPTP Poisoning	2013
Anticardiolipin antibody in vascular parkinsonism. Movement disorders : official journal of the Movement Disorder Society, 2002, Volume: 17, Issue:5 Topics: Aged; Antibodies, Anticardiolipin; Antiparkinson Agents; Brain; Brain Ischemia; Cerebrovascular Circulation; Cognition Disorders; Female; Gait; Humans; Levodopa; Lower Extremity; Male; Neuropsychological Tests; Parkinson Disease, Secondary; Posture; Risk Factors	2002
Cognitive slowing in Parkinson's disease resolves after practice. Journal of neurology, neurosurgery, and psychiatry, 2002, Volume: 73, Issue:5 Topics: Aged; Antiparkinson Agents; Cognition Disorders; Humans; Levodopa; Middle Aged; Neuropsychological Tests; Parkinson Disease; Psychomotor Performance; Random Allocation; Reaction Time; Severity of Illness Index	2002
Motivation, reward, and Parkinson's disease: influence of dopatherapy. Neuropsychologia, 2002, Volume: 40, Issue:13 Topics: Adult; Antiparkinson Agents; Cognition Disorders; Corpus Striatum; Depressive Disorder, Major; Extinction, Psychological; Female; Frontal Lobe; Humans; Levodopa; Male; Motivation; Nerve Net; Neuropsychological Tests; Parkinson Disease; Reinforcement, Psychology; Reward	2002
Acute psychotropic effects of bilateral subthalamic nucleus stimulation and levodopa in Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 2003, Volume: 18, Issue:5 Topics: Activities of Daily Living; Aged; Antiparkinson Agents; Cognition Disorders; Depressive Disorder, Major; Electric Stimulation Therapy; Female; Frontal Lobe; Functional Laterality; Humans; Levodopa; Male; Middle Aged; Neuropsychological Tests; Parkinson Disease; Psychological Tests; Psychomotor Disorders; Severity of Illness Index; Subthalamic Nucleus; Surveys and Questionnaires; Time	2003
Emotion recognition in patients with idiopathic Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 2003, Volume: 18, Issue:10 Topics: Aged; Antiparkinson Agents; Attention; Case-Control Studies; Cognition Disorders; Discrimination, Psychological; Emotions; Facial Expression; Female; Functional Laterality; Humans; Levodopa; Male; Middle Aged; Neuropsychological Tests; Parkinson Disease; Recognition, Psychology; Visual Perception	2003
Continuous apomorphine infusion and neuropsychiatric disorders: a controlled study in patients with advanced Parkinson's disease. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2003, Volume: 24, Issue:3 Topics: Aged; Apomorphine; Cognition Disorders; Dopamine Agonists; Drug Administration Routes; Drug Administration Schedule; Humans; Levodopa; Longitudinal Studies; Middle Aged; Motor Activity; Neuropsychological Tests; Parkinson Disease; Psychiatric Status Rating Scales	2003
Deficit of short-term memory in newly diagnosed untreated parkinsonian patients: reversal after L-dopa therapy. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2003, Volume: 24, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Cognition Disorders; Cross-Sectional Studies; Dopamine Agents; Drug Evaluation; Female; Humans; Language Tests; Levodopa; Male; Memory Disorders; Memory, Short-Term; Middle Aged; Neuropsychological Tests; Parkinson Disease; Verbal Learning	2003
Parkinson's disease, subthalamic stimulation, and selection of candidates: a pathological study. Movement disorders : official journal of the Movement Disorder Society, 2003, Volume: 18, Issue:12 Topics: Aged; Antiparkinson Agents; Cognition Disorders; Disease Progression; Dyskinesia, Drug-Induced; Electric Stimulation Therapy; Fatal Outcome; Female; Humans; Levodopa; Neuropsychological Tests; Parkinson Disease; Subthalamic Nucleus; Tremor	2003
Punding in Parkinson's disease: its relation to the dopamine dysregulation syndrome. Movement disorders : official journal of the Movement Disorder Society, 2004, Volume: 19, Issue:4 Topics: Aged; Cognition Disorders; Dopamine; Dopamine Agonists; Female; Humans; Injections, Subcutaneous; Levodopa; Male; Middle Aged; Neuropsychological Tests; Obsessive-Compulsive Disorder; Occupations; Parkinson Disease; Stereotyped Behavior; Videotape Recording	2004
[Cognitive deficits in progressive supranuclear palsy]. Neurologia i neurochirurgia polska, 2003, Volume: 37 Suppl 5 Topics: Aged; Antiparkinson Agents; Cognition Disorders; Female; Humans; Levodopa; Middle Aged; Neuropsychological Tests; Supranuclear Palsy, Progressive	2003
Assessing comorbidity in patients with Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 2004, Volume: 19, Issue:7 Topics: Activities of Daily Living; Aged; Antiparkinson Agents; Cognition Disorders; Comorbidity; Disability Evaluation; Gastrointestinal Diseases; Humans; Levodopa; Male; Male Urogenital Diseases; Neuropsychological Tests; Parkinson Disease; Primary Health Care; Surveys and Questionnaires	2004
Markedly asymmetrical parkinsonism as a leading feature of adult-onset Huntington's disease. Movement disorders : official journal of the Movement Disorder Society, 2004, Volume: 19, Issue:7 Topics: Adult; Alleles; Antiparkinson Agents; Carbidopa; Cognition Disorders; Diagnosis, Differential; Drug Combinations; Humans; Huntington Disease; Levodopa; Male; Neuropsychological Tests; Parkinsonian Disorders; Pedigree; Severity of Illness Index	2004
Levodopa-responsive parkinsonism in hereditary spastic paraplegia with thin corpus callosum. Parkinsonism & related disorders, 2004, Volume: 10, Issue:7 Topics: Adolescent; Antiparkinson Agents; Benztropine; Cognition Disorders; Corpus Callosum; Electroencephalography; Female; Gait Disorders, Neurologic; Humans; Levodopa; Magnetic Resonance Imaging; Male; Muscle Weakness; Neuropsychological Tests; Parkinson Disease; Selegiline; Spastic Paraplegia, Hereditary; Tremor	2004
[Influence of levodopa on cognition of idiopathic Parkinson's disease]. Neurologia (Barcelona, Spain), 2004, Volume: 19, Issue:10 Topics: Antiparkinson Agents; Cognition Disorders; Female; Humans; Levodopa; Male; Middle Aged; Neuropsychological Tests; Parkinson Disease	2004
[Cognitive dysfunction in patients with Parkinson's disease]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2005, Volume: 105, Issue:1 Topics: Aged; Antiparkinson Agents; Cholinergic Antagonists; Cognition Disorders; Dementia; Dopamine Agonists; Female; Frontal Lobe; Functional Laterality; Hippocampus; Humans; Levodopa; Male; Middle Aged; Monoamine Oxidase Inhibitors; Movement Disorders; Neuropsychological Tests; Parkinson Disease; Severity of Illness Index	2005
Patient-perceived involvement and satisfaction in Parkinson's disease: effect on therapy decisions and quality of life. Movement disorders : official journal of the Movement Disorder Society, 2005, Volume: 20, Issue:5 Topics: Activities of Daily Living; Antiparkinson Agents; Cognition Disorders; Cohort Studies; Communication; Decision Making; Female; Humans; Levodopa; Male; Middle Aged; Neuropsychological Tests; Parkinson Disease; Patient Participation; Patient Satisfaction; Quality of Life; Severity of Illness Index; Surveys and Questionnaires	2005
Identification of motor and nonmotor wearing-off in Parkinson's disease: comparison of a patient questionnaire versus a clinician assessment. Movement disorders : official journal of the Movement Disorder Society, 2005, Volume: 20, Issue:6 Topics: Activities of Daily Living; Adult; Age Factors; Aged; Aged, 80 and over; Case-Control Studies; Cognition; Cognition Disorders; Disability Evaluation; Female; Humans; Levodopa; Male; Middle Aged; Motor Activity; Movement Disorders; Outcome Assessment, Health Care; Parkinson Disease; Retrospective Studies; Severity of Illness Index; Surveys and Questionnaires	2005
Sepiapterin reductase deficiency: a congenital dopa-responsive motor and cognitive disorder. Brain : a journal of neurology, 2005, Volume: 128, Issue:Pt 10 Topics: Adolescent; Alcohol Oxidoreductases; Cerebral Palsy; Child; Child, Preschool; Circadian Rhythm; Cognition Disorders; Developmental Disabilities; Dopamine Agents; Dyskinesias; Female; Genotype; Humans; Levodopa; Male; Motor Activity; Movement Disorders	2005
Plasma homocysteine levels in L-dopa-treated Parkinson's disease patients with cognitive dysfunctions. Clinical chemistry and laboratory medicine, 2005, Volume: 43, Issue:10 Topics: Aged; Case-Control Studies; Cognition Disorders; Female; Homocysteine; Humans; Levodopa; Male; Middle Aged; Parkinson Disease	2005
Association of homocysteine with plasma amyloid beta protein in aging and neurodegenerative disease. Neurology, 2005, Nov-08, Volume: 65, Issue:9 Topics: Aged; Aged, 80 and over; Aging; Alzheimer Disease; Amyloid beta-Peptides; Brain; Causality; Cerebral Amyloid Angiopathy; Cognition Disorders; Creatinine; Female; Folic Acid; Homocysteine; Humans; Levodopa; Male; Memory Disorders; Middle Aged; Neurodegenerative Diseases; Parkinson Disease; Predictive Value of Tests; Vitamin B 12	2005
Stimulation of the subthalamic nucleus in Parkinson's disease: a 5 year follow up. Journal of neurology, neurosurgery, and psychiatry, 2005, Volume: 76, Issue:12 Topics: Activities of Daily Living; Aged; Antiparkinson Agents; Cognition Disorders; Deep Brain Stimulation; Disease Progression; Female; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Motor Skills Disorders; Parkinson Disease; Subthalamic Nucleus; Treatment Outcome	2005
Clinical and neuropsychological follow up at 12 months in patients with complicated Parkinson's disease treated with subcutaneous apomorphine infusion or deep brain stimulation of the subthalamic nucleus. Journal of neurology, neurosurgery, and psychiatry, 2006, Volume: 77, Issue:4 Topics: Aged; Antiparkinson Agents; Apomorphine; Cognition Disorders; Deep Brain Stimulation; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Injections, Subcutaneous; Levodopa; Male; Middle Aged; Neuropsychological Tests; Parkinson Disease; Severity of Illness Index; Subthalamic Nucleus	2006
Diagnostic aspects of early Parkinson's disease. Journal of neurology, 2006, Volume: 253 Suppl 4 Topics: Antiparkinson Agents; Brain; Cognition Disorders; Depression; Humans; Levodopa; Parkinson Disease; Perceptual Disorders	2006
Phenomenology of dreams in Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 2007, Jan-15, Volume: 22, Issue:2 Topics: Aged; Antiparkinson Agents; Cognition Disorders; Dreams; Female; Humans; Levodopa; Male; Neuropsychological Tests; Parkinson Disease; Semantics; Severity of Illness Index; Sleep Wake Disorders; Sleep, REM	2007
[Akatinol memantine in the therapy of cognitive disorders in Parkinson's disease]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2007, Volume: 107, Issue:1 Topics: Antiparkinson Agents; Cognition; Cognition Disorders; Dose-Response Relationship, Drug; Drug Administration Schedule; Excitatory Amino Acid Antagonists; Female; Follow-Up Studies; Humans; Levodopa; Male; Memantine; Middle Aged; Parkinson Disease; Severity of Illness Index; Time Factors; Treatment Outcome	2007
Slowing of oscillatory brain activity is a stable characteristic of Parkinson's disease without dementia. Brain : a journal of neurology, 2007, Volume: 130, Issue:Pt 7 Topics: Aged; Antiparkinson Agents; Biological Clocks; Brain; Cognition Disorders; Dose-Response Relationship, Drug; Female; Humans; Levodopa; Magnetic Resonance Imaging; Magnetoencephalography; Male; Middle Aged; Neuropsychological Tests; Parkinson Disease; Severity of Illness Index; Signal Processing, Computer-Assisted; Time Factors	2007
The 39 item Parkinson's disease questionnaire (PDQ-39) revisited: implications for evidence based medicine. Journal of neurology, neurosurgery, and psychiatry, 2007, Volume: 78, Issue:11 Topics: Activities of Daily Living; Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Cognition Disorders; Disability Evaluation; Evidence-Based Medicine; Female; Geriatric Assessment; Humans; Levodopa; Male; Middle Aged; Mobility Limitation; Parkinson Disease; Psychometrics; Quality of Life; Reproducibility of Results; Sick Role; Surveys and Questionnaires; Sweden	2007
Patterns of levodopa response in Parkinson's disease: a clinico-pathological study. Brain : a journal of neurology, 2007, Volume: 130, Issue:Pt 8 Topics: Accidental Falls; Adult; Age Factors; Age of Onset; Aged; Aged, 80 and over; Antiparkinson Agents; Cognition Disorders; Disease Progression; Female; Hallucinations; Humans; Levodopa; Lewy Bodies; Male; Middle Aged; Parkinson Disease; Retrospective Studies; Severity of Illness Index; Treatment Outcome	2007
Dopaminergic modulation of cognitive interference after pharmacological washout in Parkinson's disease. Brain research bulletin, 2007, Sep-14, Volume: 74, Issue:1-3 Topics: Analysis of Variance; Antiparkinson Agents; Brain Mapping; Cognition Disorders; Dopamine; Female; Humans; Image Processing, Computer-Assisted; Levodopa; Magnetic Resonance Imaging; Male; Middle Aged; Neuropsychological Tests; Oxygen; Parkinson Disease; Prefrontal Cortex; Random Allocation; Reaction Time	2007
Participation of the subthalamic nucleus in executive functions: An intracerebral recording study. Movement disorders : official journal of the Movement Disorder Society, 2008, Mar-15, Volume: 23, Issue:4 Topics: Antiparkinson Agents; Cognition Disorders; Deep Brain Stimulation; Dyskinesia, Drug-Induced; Evoked Potentials; Female; Humans; Levodopa; Male; Microelectrodes; Middle Aged; Neuropsychological Tests; Parkinson Disease; Subthalamic Nucleus	2008
Attentional control in Parkinson's disease is dependent on COMT val 158 met genotype. Brain : a journal of neurology, 2008, Volume: 131, Issue:Pt 2 Topics: Aged; Antiparkinson Agents; Attention; Brain Mapping; Catechol O-Methyltransferase; Cognition Disorders; Female; Frontal Lobe; Genotype; Humans; Levodopa; Magnetic Resonance Imaging; Male; Middle Aged; Neuropsychological Tests; Parkinson Disease; Photic Stimulation; Polymorphism, Genetic; Prefrontal Cortex	2008
[Impaired recognition of emotion improved by L-DOPA in a patient with amygdala damage]. Rinsho shinkeigaku = Clinical neurology, 2008, Volume: 48, Issue:2 Topics: Affective Symptoms; Aged; Amygdala; Cerebral Cortex; Cognition Disorders; Dopamine; Encephalitis, Herpes Simplex; Female; Humans; Levodopa	2008
Identification of the novel D297fsX318 PINK1 mutation and phenotype variation in a family with early-onset Parkinson's disease. Parkinsonism & related disorders, 2008, Volume: 14, Issue:6 Topics: Age of Onset; Aged; Amino Acid Sequence; Antiparkinson Agents; Cognition Disorders; Exons; Gene Deletion; Genotype; Humans; Levodopa; Male; Molecular Sequence Data; Mutation; Parkinson Disease; Pedigree; Phenotype; Protein Kinases	2008
Parkinson's disease-cognitive rating scale: a new cognitive scale specific for Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 2008, May-15, Volume: 23, Issue:7 Topics: Aged; Brain; Cognition Disorders; Female; Frontal Lobe; Humans; Levodopa; Male; Neuropsychological Tests; Parkinson Disease; Prospective Studies; Reproducibility of Results; Severity of Illness Index; Surveys and Questionnaires	2008
Cognition and the basal ganglia. Separating mental and motor components of performance in Parkinson's disease. Brain : a journal of neurology, 1984, Volume: 107 ( Pt 4) Topics: Adult; Aged; Attention; Basal Ganglia; Carbidopa; Cognition Disorders; Female; Humans; Levodopa; Male; Memory; Middle Aged; Motor Activity; Movement; Parkinson Disease; Reaction Time	1984
Neuropsychological disturbances and cerebral atrophy determined by computerized tomography in parkinsonian patients with long-term levodopa treatment. Advances in neurology, 1984, Volume: 40 Topics: Brain; Cognition Disorders; Dementia; Humans; Levodopa; Parkinson Disease; Tomography, X-Ray Computed	1984
Confusion, dementia and anticholinergics in Parkinson's disease. Journal of neurology, neurosurgery, and psychiatry, 1982, Volume: 45, Issue:12 Topics: Cognition Disorders; Confusion; Dementia; Drug Therapy, Combination; Humans; Levodopa; Parasympatholytics; Parkinson Disease	1982
[Gait disorders and repeated falls in Steele-Richardson-Olszewski syndrome]. Tijdschrift voor gerontologie en geriatrie, 1995, Volume: 26, Issue:4 Topics: Accidental Falls; Aged; Cognition Disorders; Female; Gait; Humans; Levodopa; Magnetic Resonance Spectroscopy; Movement Disorders; Neurotransmitter Agents; Posture; Saccades; Supranuclear Palsy, Progressive; Tomography, X-Ray Computed	1995
Which factors predict cognitive decline in Parkinson's disease? Journal of neurology, neurosurgery, and psychiatry, 1995, Volume: 58, Issue:1 Topics: Activities of Daily Living; Age of Onset; Aged; Cognition Disorders; Depressive Disorder; Educational Status; Humans; Levodopa; Middle Aged; Movement Disorders; Neuropsychological Tests; Parkinson Disease; Prognosis; Severity of Illness Index; Task Performance and Analysis; Tremor	1995
Hypothesis: the bradyphrenia of parkinsonism is a nosological entity. Acta neurologica Scandinavica, 1993, Volume: 87, Issue:4 Topics: Adult; Aged; Aging; Alcohol Drinking; Antiparkinson Agents; Cognition; Cognition Disorders; Depressive Disorder; Ethanol; Female; Humans; Levodopa; Male; Middle Aged; Motor Skills; Parkinson Disease; Probability; Psychological Tests; Reaction Time	1993
Dopa responsive dystonia with Turner's syndrome: clinical, genetic, and neuropsychological studies in a family with a new mutation in the GTP-cyclohydrolase I gene. Journal of neurology, neurosurgery, and psychiatry, 1998, Volume: 64, Issue:6 Topics: Adult; Antiparkinson Agents; Brain; Chromosome Aberrations; Chromosome Disorders; Chromosomes, Human, Pair 14; Cognition Disorders; Dystonia; Exons; Female; GTP Cyclohydrolase; Humans; Levodopa; Magnetic Resonance Imaging; Middle Aged; Neuropsychological Tests; Pedigree; Point Mutation; Turner Syndrome	1998
Dopaminergic influences on the P300 abnormality in Parkinson's disease. Journal of the neurological sciences, 1998, Jun-11, Volume: 158, Issue:1 Topics: Acoustic Stimulation; Aged; Antiparkinson Agents; Cholinergic Antagonists; Cognition Disorders; Dopamine; Dopamine Agonists; Drug Therapy, Combination; Electroencephalography; Event-Related Potentials, P300; Female; Humans; Levodopa; Longitudinal Studies; Male; Mental Processes; Middle Aged; Parkinson Disease; Reaction Time; Severity of Illness Index	1998
Cognitive functioning after pallidotomy for refractory Parkinson's disease. Journal of neurology, neurosurgery, and psychiatry, 1998, Volume: 65, Issue:2 Topics: Activities of Daily Living; Aged; Cognition Disorders; Combined Modality Therapy; Female; Follow-Up Studies; Globus Pallidus; Humans; Levodopa; Male; Middle Aged; Neuropsychological Tests; Parkinson Disease; Postoperative Complications; Stereotaxic Techniques; Treatment Outcome	1998
Young-onset Parkinson's disease revisited--clinical features, natural history, and mortality. Movement disorders : official journal of the Movement Disorder Society, 1998, Volume: 13, Issue:6 Topics: Adolescent; Adult; Age Factors; Age of Onset; Antiparkinson Agents; Cause of Death; Chi-Square Distribution; Cognition Disorders; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Likelihood Functions; Male; Parkinson Disease; Poisson Distribution; Risk Factors	1998
Parkinsonism, pyramidal signs, polyneuropathy, and cognitive decline after long-term occupational solvent exposure. Journal of neurology, 1999, Volume: 246, Issue:3 Topics: Aged; Brain; Cognition Disorders; Humans; Levodopa; Male; Middle Aged; Occupational Exposure; Paint; Parkinson Disease, Secondary; Solvents	1999
Nicotinic acetylcholine receptor agonist SIB-1508Y improves cognitive functioning in chronic low-dose MPTP-treated monkeys. The Journal of pharmacology and experimental therapeutics, 1999, Volume: 290, Issue:2 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Attention; Cognition Disorders; Conditioning, Operant; Discrimination Learning; Dopamine Agents; Female; Levodopa; Macaca fascicularis; Macaca nemestrina; Male; Memory, Short-Term; Nicotine; Nicotinic Agonists; Pattern Recognition, Visual; Pyridines; Pyrrolidines; Receptors, Nicotinic; Space Perception	1999
Neuropsychological outcome of GPi pallidotomy and GPi or STN deep brain stimulation in Parkinson's disease. Brain and cognition, 2000, Volume: 42, Issue:3 Topics: Adult; Aged; Basal Ganglia; Brain; Cognition Disorders; Dyskinesia, Drug-Induced; Electric Stimulation; Female; Globus Pallidus; Humans; Levodopa; Magnetic Resonance Imaging; Male; Middle Aged; Neuropsychological Tests; Neurosurgical Procedures; Parkinson Disease; Postoperative Complications; Preoperative Care; Subthalamic Nucleus; Surveys and Questionnaires	2000
Establishment of L-3,4-Dihydroxyphenilalaninde-induced pharmacological dementia model mouse. Neuroscience letters, 2001, Jun-08, Volume: 305, Issue:2 Topics: Administration, Oral; Animals; Antiparkinson Agents; Avoidance Learning; Cognition Disorders; Dementia; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Levodopa; Male; Memory Disorders; Mice; Mice, Inbred C57BL; Stereoisomerism	2001
Dopaminergic modulation of high-level cognition in Parkinson's disease: the role of the prefrontal cortex revealed by PET. Brain : a journal of neurology, 2002, Volume: 125, Issue:Pt 3 Topics: Brain; Cerebrovascular Circulation; Cognition; Cognition Disorders; Dopamine; Dopamine Agents; Female; Humans; Levodopa; Male; Memory, Short-Term; Middle Aged; Parkinson Disease; Prefrontal Cortex; Psychomotor Performance; Tomography, Emission-Computed	2002
[Concentration of 3'5' cyclic adenosine monophosphate in lumbar cerebrospinal fluid and in plasma of patients with consciousness disturbances (author's transl)]. No to shinkei = Brain and nerve, 1979, Volume: 31, Issue:8 Topics: Adolescent; Adult; Aged; Cognition Disorders; Consciousness Disorders; Cyclic AMP; Female; Humans; Intracranial Aneurysm; Levodopa; Male; Middle Aged; Thyrotropin-Releasing Hormone	1979
[Treatment of reactive stuporous states with L-DOPA]. Zhurnal nevropatologii i psikhiatrii imeni S.S. Korsakova (Moscow, Russia : 1952), 1978, Volume: 78, Issue:4 Topics: Adult; Antidepressive Agents; Catecholamines; Cognition Disorders; Consciousness Disorders; Humans; Levodopa; Middle Aged; Psychotic Disorders; Schizophrenia; Syndrome	1978
Cognitive deficits associated with chronic hepatic encephalopathy and their response to levodopa. Journal of neurology, neurosurgery, and psychiatry, 1975, Volume: 38, Issue:8 Topics: Adult; Aged; Cognition Disorders; Female; Hepatic Encephalopathy; Humans; Levodopa; Male; Memory, Short-Term; Middle Aged; Reaction Time; Time Factors	1975
[The deterioration of patients with parkinsonism treated with L-dopa]. La Nouvelle presse medicale, 1975, Oct-18, Volume: 4, Issue:35 Topics: Aged; Cognition Disorders; Follow-Up Studies; Humans; Levodopa; Middle Aged; Movement Disorders; Muscle Tonus; Parkinson Disease; Postural Balance; Recurrence; Tremor	1975
Dream structure in Parkinson's patients. The Journal of nervous and mental disease, 1992, Volume: 180, Issue:8 Topics: Age Factors; Aged; Ambulatory Care; Cognition Disorders; Dose-Response Relationship, Drug; Dreams; Female; Humans; Language Tests; Levodopa; Male; Mental Recall; Middle Aged; Neuropsychological Tests; Parkinson Disease; Time Factors	1992
Somatostatin-like immunoreactivity in the cerebrospinal fluid of aged patients with Parkinson's disease. The effect of dopatherapy. Journal of the American Geriatrics Society, 1990, Volume: 38, Issue:1 Topics: Aged; Aged, 80 and over; Benserazide; Bromocriptine; Cognition Disorders; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Levodopa; Male; Parkinson Disease; Severity of Illness Index; Somatostatin	1990
Autonomic involvement in extrapyramidal and cerebellar disorders. Clinical autonomic research : official journal of the Clinical Autonomic Research Society, 1991, Volume: 1, Issue:2 Topics: Adult; Aged; Antiparkinson Agents; Autonomic Nervous System Diseases; Basal Ganglia Diseases; Cerebellar Diseases; Cognition Disorders; Female; Heart Rate; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Reflex; Shy-Drager Syndrome; Supranuclear Palsy, Progressive; Valsalva Maneuver	1991
Dopaminergic induced changes in cognitive and motor processing in Parkinson's disease: an electrophysiological investigation. Journal of neurology, neurosurgery, and psychiatry, 1991, Volume: 54, Issue:7 Topics: Adult; Aged; Antiparkinson Agents; Carbidopa; Cerebral Cortex; Cognition Disorders; Dopamine; Dose-Response Relationship, Drug; Drug Combinations; Electroencephalography; Evoked Potentials; Female; Humans; Levodopa; Male; Middle Aged; Neurologic Examination; Parkinson Disease; Psychomotor Performance; Reaction Time; Receptors, Dopamine	1991
Cognitive deficiency induced by the acute stress in rats: a possible role of brain catecholaminergic systems. Annali dell'Istituto superiore di sanita, 1990, Volume: 26, Issue:1 Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Benserazide; Brain Chemistry; Cognition Disorders; Dihydroxyphenylalanine; Escape Reaction; Exploratory Behavior; Levodopa; Male; Norepinephrine; Rats; Stress, Physiological	1990
Cholinergic deficiency and frontal dysfunction in Parkinson's disease. Annals of neurology, 1990, Volume: 28, Issue:2 Topics: Afferent Pathways; Cholinergic Fibers; Cognition Disorders; Frontal Lobe; Humans; Levodopa; Parasympatholytics; Parkinson Disease; Psychological Tests	1990
Depression in Parkinson's disease. The Journal of nervous and mental disease, 1990, Volume: 178, Issue:1 Topics: Cognition Disorders; Depression; Dose-Response Relationship, Drug; Humans; Levodopa; Neurologic Examination; Parkinson Disease; Psychiatric Status Rating Scales	1990
Does cognitive impairment in Parkinson's disease result from non-dopaminergic lesions? Journal of neurology, neurosurgery, and psychiatry, 1989, Volume: 52, Issue:2 Topics: Adult; Aged; Cognition Disorders; Dopamine; Frontal Lobe; Humans; Levodopa; Middle Aged; Motor Skills; Neuropsychological Tests; Parkinson Disease; Receptors, Dopamine	1989
[The mental state of parkinsonian patients]. La Revue du praticien, 1989, Mar-09, Volume: 39, Issue:8 Topics: Cognition Disorders; Dementia; Depression; Humans; Levodopa; Mental Disorders; Parkinson Disease	1989
[Parkinson disease and cognitive evoked potentials]. Revue neurologique, 1989, Volume: 145, Issue:3 Topics: Age Factors; Cognition Disorders; Evoked Potentials, Auditory; Female; Humans; Levodopa; Male; Neuropsychological Tests; Parkinson Disease; Reaction Time	1989
Acute postoperative confusion and hallucinations in Parkinson disease. Annals of internal medicine, 1989, Aug-01, Volume: 111, Issue:3 Topics: Aged; Aged, 80 and over; Carbidopa; Cognition Disorders; Confusion; Drug Combinations; Female; Hallucinations; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Postoperative Complications; Retrospective Studies; Risk	1989
Depression and cognitive impairment in Parkinson's disease. Brain : a journal of neurology, 1989, Volume: 112 ( Pt 5) Topics: Cognition; Cognition Disorders; Depression; Humans; Language Tests; Levodopa; Neuropsychological Tests; Parkinson Disease; Regression Analysis	1989
Psychopharmacological investigations of a lead-induced long-term cognitive deficit in monkeys. Psychopharmacology, 1987, Volume: 91, Issue:3 Topics: Acetylcholine; Amphetamine; Animals; Behavior, Animal; Cognition Disorders; Dopamine; Haloperidol; Lead Poisoning; Levodopa; Macaca mulatta; Physostigmine; Scopolamine; Sulpiride	1987
[Metrizamide encephalopathy in a child with hydrocephalus--effects of L-threo-DOPS on persistent disturbance of consciousness and L-dopa on extrapyramidal symptoms]. No to shinkei = Brain and nerve, 1988, Volume: 40, Issue:11 Topics: Basal Ganglia Diseases; Brain; Brain Diseases; Child; Cognition Disorders; Consciousness Disorders; Droxidopa; Electroencephalography; Extravasation of Diagnostic and Therapeutic Materials; Female; Humans; Hydrocephalus; Levodopa; Metrizamide; Serine; Tomography, X-Ray Computed	1988
Sudden onset of confusion with severe exacerbation of parkinsonism during levodopa therapy. Movement disorders : official journal of the Movement Disorder Society, 1986, Volume: 1, Issue:4 Topics: Aged; Carbidopa; Cognition Disorders; Confusion; Dose-Response Relationship, Drug; Drug Combinations; Humans; Levodopa; Male; Parkinson Disease, Secondary	1986
Sudden confusion with levodopa withdrawal. Movement disorders : official journal of the Movement Disorder Society, 1987, Volume: 2, Issue:3 Topics: Cognition Disorders; Confusion; Humans; Levodopa; Parkinson Disease; Parkinson Disease, Secondary; Substance Withdrawal Syndrome	1987
Predictive factors for cognitive deterioration and dementia in Parkinson's disease. Advances in neurology, 1987, Volume: 45 Topics: Cognition Disorders; Dementia; Electroencephalography; Homovanillic Acid; Humans; Levodopa; Parkinson Disease; Prognosis	1987